An updated review on diverse range of biological activities of 1,2,4-triazole derivatives: Insight into structure activity relationship
•1,2,4-Triazole based aromatic and heterocyclic compounds holds tremendous potential in the medicinal chemistry.•Different biological targets for 1,2,4-triazole analogs have been discussed with their biological activity.•Synthetic strategy and SAR for the various biological activities of 1,2,4-triaz...
Saved in:
| Published in | Journal of molecular structure Vol. 1274; p. 134487 |
|---|---|
| Main Authors | , , |
| Format | Journal Article |
| Language | English |
| Published |
Elsevier B.V
15.02.2023
|
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | •1,2,4-Triazole based aromatic and heterocyclic compounds holds tremendous potential in the medicinal chemistry.•Different biological targets for 1,2,4-triazole analogs have been discussed with their biological activity.•Synthetic strategy and SAR for the various biological activities of 1,2,4-triazole have been discussed.•This compilation includes the research work reported on 1,2,4-triazole-based compounds from 2011 to 2022.
Since its discovery 1,2,4-triazole ring has emerged as a prominent heterocyclic scaffold in medicinal chemistry. It possesses a wide spectrum of biological activities such as antimicrobial, anticancer, antiepileptic, anti-inflammatory, antiviral, antihypertensive, sedative-hypnotic, etc. Its wide biological profile has always been a subject of interest that have attracted researchers to investigate the pharmacophoric features of this skeleton. In the past few years, significant progress has been made in the medicinal chemistry of 1,2,4-triazole-based derivatives. The current review summarizes the synthetic approaches that have been designed along with the diverse biological activities of 1,2,4-triazole-based compounds reported in the last decade. We hope that this review will be highly beneficial for the researchers and medicinal chemists engaged in exploring 1,2,4-triazole as a potential lead for drug design and discovery.
The review summarizes the synthetic strategies, biological activity and SARs of 1,2,4-triazole based compounds. This review can serve as crucial lead for the development of novel small molecules for wide variety of medicinal applications. [Display omitted] |
|---|---|
| AbstractList | •1,2,4-Triazole based aromatic and heterocyclic compounds holds tremendous potential in the medicinal chemistry.•Different biological targets for 1,2,4-triazole analogs have been discussed with their biological activity.•Synthetic strategy and SAR for the various biological activities of 1,2,4-triazole have been discussed.•This compilation includes the research work reported on 1,2,4-triazole-based compounds from 2011 to 2022.
Since its discovery 1,2,4-triazole ring has emerged as a prominent heterocyclic scaffold in medicinal chemistry. It possesses a wide spectrum of biological activities such as antimicrobial, anticancer, antiepileptic, anti-inflammatory, antiviral, antihypertensive, sedative-hypnotic, etc. Its wide biological profile has always been a subject of interest that have attracted researchers to investigate the pharmacophoric features of this skeleton. In the past few years, significant progress has been made in the medicinal chemistry of 1,2,4-triazole-based derivatives. The current review summarizes the synthetic approaches that have been designed along with the diverse biological activities of 1,2,4-triazole-based compounds reported in the last decade. We hope that this review will be highly beneficial for the researchers and medicinal chemists engaged in exploring 1,2,4-triazole as a potential lead for drug design and discovery.
The review summarizes the synthetic strategies, biological activity and SARs of 1,2,4-triazole based compounds. This review can serve as crucial lead for the development of novel small molecules for wide variety of medicinal applications. [Display omitted] |
| ArticleNumber | 134487 |
| Author | Pradhan, Tathagata Chawla, Gita Gupta, Ojasvi |
| Author_xml | – sequence: 1 givenname: Ojasvi surname: Gupta fullname: Gupta, Ojasvi – sequence: 2 givenname: Tathagata surname: Pradhan fullname: Pradhan, Tathagata – sequence: 3 givenname: Gita orcidid: 0000-0003-1745-9697 surname: Chawla fullname: Chawla, Gita email: gchawla@jamiahamdard.ac.in |
| BookMark | eNqFkE1OwzAQRi1UJErhCsgHaIrtOE2CWFBV_ElIbGBtOfakTBXsynaL4AJcm7SlGzasZjHzvpl5p2TgvANCLjibcManl8vJu-9iCmszEUyICc-lrMojMuRVKbKKcTkgQ9Z3MlFN2Qk5jXHJGOM9PCTfM0fXK6sTWBpgg_BBvaMWNxAi0KDdAqhvaYO-8ws0uqPaJNxgQojbBh-LscxSQP3lO6AWAm50PwDxij66iIu3RNElT3cHpnWAQ8Bnv6_rR72Lb7g6I8et7iKc_9YReb27fZk_ZE_P94_z2VNmci5SVtVsWhVcly1YbVtb1rKqJeelyFswvC1z1hRa2KIWhanzpuENSFZImRfGNGWbj8j1PtcEH2OAVhlMuytS0NgpztRWqlqqg1S1lar2Unt8-gdfBXzX4fN_8GYPQv9crzmoaBCcAYsBTFLW438RPzlqm4Y |
| CitedBy_id | crossref_primary_10_1016_j_micpath_2024_107209 crossref_primary_10_3390_biom14121529 crossref_primary_10_3390_M1740 crossref_primary_10_3390_molecules28093808 crossref_primary_10_1016_j_molstruc_2023_136953 crossref_primary_10_1016_j_bioorg_2024_107662 crossref_primary_10_18596_jotcsa_1371936 crossref_primary_10_1007_s10593_024_03343_x crossref_primary_10_1007_s00706_023_03119_7 crossref_primary_10_1107_S2052520624002427 crossref_primary_10_1007_s11030_024_10858_0 crossref_primary_10_1016_j_molstruc_2024_139960 crossref_primary_10_1016_j_rechem_2024_101516 crossref_primary_10_3390_jfb15060138 crossref_primary_10_1002_adsc_202401251 crossref_primary_10_1016_j_molstruc_2024_139963 crossref_primary_10_1016_j_molstruc_2023_135461 crossref_primary_10_3390_antibiotics12071220 crossref_primary_10_1016_j_steroids_2024_109499 crossref_primary_10_1016_j_molstruc_2024_137517 crossref_primary_10_1002_slct_202402258 crossref_primary_10_1080_07391102_2023_2226743 crossref_primary_10_1002_ardp_202400406 crossref_primary_10_32628_IJSRST2310166 crossref_primary_10_1002_cbdv_202400043 crossref_primary_10_1080_17518253_2024_2307989 crossref_primary_10_6023_cjoc202302012 crossref_primary_10_1016_j_molstruc_2024_139978 crossref_primary_10_1007_s13369_023_08137_5 crossref_primary_10_3390_ph17050548 crossref_primary_10_1002_ardp_202400562 crossref_primary_10_1039_D4NJ04551C crossref_primary_10_2174_0115680266307132240509065351 crossref_primary_10_1016_j_imu_2023_101332 crossref_primary_10_1055_s_0042_1751636 crossref_primary_10_3389_fchem_2024_1395008 crossref_primary_10_3390_antibiotics13080763 crossref_primary_10_1016_j_eurpolymj_2024_113483 crossref_primary_10_1016_j_molstruc_2023_137197 |
| Cites_doi | 10.1055/s-0034-1379734 10.1016/j.bioorg.2019.103355 10.1016/j.molstruc.2020.129446 10.1016/j.bioorg.2021.105049 10.2165/00003495-200868090-00007 10.1016/j.ejmech.2014.09.034 10.1016/j.mencom.2021.04.029 10.3762/bjoc.7.79 10.2174/1389557519666190312162601 10.2165/00003495-200262100-00007 10.1016/j.bmcl.2017.03.062 10.2174/157340710793237281 10.1016/j.molstruc.2021.130346 10.1002/jhet.3286 10.2165/00002512-199711030-00007 10.1016/j.sleep.2015.05.021 10.2165/00003495-198427020-00002 10.1086/367933 10.1016/j.bioorg.2018.08.031 10.1002/j.1552-4604.1990.tb03486.x 10.1039/D0RA01378A 10.1016/j.heliyon.2020.e05290 10.1016/j.bmc.2013.10.017 10.3390/pharmaceutics13111961 10.1016/j.bmcl.2015.04.079 10.2174/1389557519666190312152358 10.2174/1568026621666210913122828 10.1111/j.1368-5031.2004.00167.x 10.1093/cid/civ571 10.1007/s13369-020-04626-z 10.2174/1573406415666190409112209 10.1002/jhet.2741 10.1021/acs.joc.5b00956 10.1016/j.molstruc.2018.12.008 10.2165/00003495-199856060-00020 10.1016/j.ejphar.2012.06.023 10.3390/molecules25081909 10.1021/cr60143a001 10.1186/2008-2231-22-22 10.1016/j.molstruc.2018.09.046 10.23939/chcht14.02.214 10.3390/life11010016 10.1016/S1473-3099(05)70297-8 10.1016/j.ejmech.2020.112625 10.2165/11203940-000000000-00000 10.1007/BF01259336 10.1021/acs.orglett.6b00277 10.1186/s13065-020-00717-y 10.1016/j.bmcl.2017.06.053 10.1016/j.bmcl.2017.08.014 10.2165/00003495-199753040-00006 10.1016/j.bmcl.2017.11.029 10.2174/1871520620666200705214917 10.1007/s13738-021-02231-x 10.1021/jo1023393 10.1021/ja905056z 10.1016/j.bioorg.2019.103260 10.1016/j.molstruc.2018.07.065 10.1016/j.ijbiomac.2019.09.105 10.1039/D0OB00350F 10.3390/molecules27030835 10.1002/jhet.3524 10.1016/0024-3205(81)90320-9 10.3390/ph14090893 10.1016/j.ejmech.2012.06.025 10.1055/s-0032-1316877 10.1016/j.bmcl.2019.04.026 10.1016/j.ejmech.2017.10.081 10.1021/acs.orglett.5b00995 10.2165/00002512-199404040-00006 10.1039/c3ob41936c 10.1016/j.ejmech.2013.06.051 10.1016/j.bioorg.2021.104920 10.1016/j.bmcl.2010.12.028 10.3390/molecules180910870 10.1016/j.ejmech.2017.12.067 10.1021/acs.orglett.5b00128 10.1080/07391102.2019.1711193 10.1111/j.1749-6632.1988.tb40385.x 10.1016/j.jksus.2020.09.026 10.1007/s00044-011-9902-z 10.1016/j.pharep.2018.06.007 10.1016/j.cclet.2013.01.047 10.4254/wjh.v8.i2.123 10.1128/AAC.36.10.2239 10.1016/j.ejmech.2013.12.014 10.1021/cr60210a001 10.3390/molecules26144213 10.1016/j.jscs.2017.07.008 10.1021/ol902207h 10.1016/j.clinthera.2007.09.015 10.1093/clinids/9.Supplement_1.S1 10.1021/jo502709t 10.1007/s11094-021-02459-0 10.3390/molecules26041162 10.1002/jhet.3791 10.1016/j.bmcl.2018.12.036 10.3390/molecules26144304 10.1016/j.tet.2012.01.003 10.1016/j.ejmech.2017.12.020 10.1016/j.ejmech.2012.11.026 10.1016/j.ejmech.2021.113392 10.1016/j.bmc.2015.03.049 10.3390/ph14030224 10.1016/j.ejmech.2012.06.059 10.1016/j.bioorg.2020.104525 10.1016/j.bmc.2017.05.054 10.5267/j.ccl.2020.7.002 10.1016/j.bioorg.2019.02.045 10.1002/jccs.201900304 10.1016/j.bioorg.2019.103519 10.1016/j.bioorg.2017.09.018 10.1016/j.ejmech.2011.06.012 10.1016/j.bioorg.2021.105261 10.1016/j.ejmech.2019.07.059 |
| ContentType | Journal Article |
| Copyright | 2022 Elsevier B.V. |
| Copyright_xml | – notice: 2022 Elsevier B.V. |
| DBID | AAYXX CITATION |
| DOI | 10.1016/j.molstruc.2022.134487 |
| DatabaseName | CrossRef |
| DatabaseTitle | CrossRef |
| DatabaseTitleList | |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Chemistry Physics |
| EISSN | 1872-8014 |
| ExternalDocumentID | 10_1016_j_molstruc_2022_134487 S0022286022021329 |
| GroupedDBID | --K --M -~X .~1 0R~ 1B1 1RT 1~. 1~5 4.4 457 4G. 5GY 5VS 7-5 71M 8P~ 9JM 9JN AACTN AAEDT AAEDW AAIAV AAIKJ AAKOC AALRI AAOAW AAQFI AARLI AAXUO ABGSF ABJNI ABMAC ABNEU ABUDA ABYKQ ACDAQ ACFVG ACGFS ACRLP ADBBV ADECG ADEZE ADUVX AEBSH AEHWI AEKER AENEX AFKWA AFTJW AFXIZ AFZHZ AGHFR AGUBO AGYEJ AHHHB AIEXJ AIKHN AITUG AIVDX AJOXV AJSZI ALMA_UNASSIGNED_HOLDINGS AMFUW AMRAJ AXJTR BKOJK BLXMC CS3 DOVZS DU5 EBS EFJIC EFLBG EO8 EO9 EP2 EP3 F5P FDB FIRID FLBIZ FNPLU FYGXN G-Q GBLVA IHE J1W KOM M36 M41 MO0 N9A O-L O9- OAUVE OGIMB OZT P-8 P-9 P2P PC. Q38 RNS ROL RPZ SDF SDG SES SPC SPCBC SSK SSQ SSU SSZ T5K TN5 UPT XPP YK3 YQT ZMT ~02 ~G- 29L 3O- 53G AAQXK AATTM AAXKI AAYWO AAYXX ABEFU ABFNM ABWVN ABXDB ACNNM ACRPL ACVFH ADCNI ADIYS ADMUD ADNMO AEIPS AEUPX AFJKZ AFPUW AGCQF AGQPQ AGRDE AGRNS AIGII AIIUN AJQLL AKBMS AKRWK AKYEP ANKPU APXCP ASPBG AVWKF AZFZN BNPGV CITATION EJD FEDTE FGOYB HMU HVGLF HZ~ H~9 R2- RIG SCB SCH SEW SSH UQL WUQ XJT XOL |
| ID | FETCH-LOGICAL-c312t-8906851a7fedadfd79489411723fec1f730b5a2d5925c93bb1be4054435ccb7f3 |
| IEDL.DBID | .~1 |
| ISSN | 0022-2860 |
| IngestDate | Thu Apr 24 22:56:41 EDT 2025 Tue Jul 01 03:47:58 EDT 2025 Fri Feb 23 02:39:04 EST 2024 |
| IsPeerReviewed | true |
| IsScholarly | true |
| Keywords | 1,2,4-Triazole Heterocyclic chemistry SAR MIC FST EAC PLK1 BRCA1/BRCA2 MPAK FLT-3 MTT PARP-1 TNF Biological activity MMP Synthesis Structure-activity relationship VEGFR-2 HD50 LSD1 IC50 Drug design PFU |
| Language | English |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c312t-8906851a7fedadfd79489411723fec1f730b5a2d5925c93bb1be4054435ccb7f3 |
| ORCID | 0000-0003-1745-9697 |
| ParticipantIDs | crossref_citationtrail_10_1016_j_molstruc_2022_134487 crossref_primary_10_1016_j_molstruc_2022_134487 elsevier_sciencedirect_doi_10_1016_j_molstruc_2022_134487 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 2023-02-15 |
| PublicationDateYYYYMMDD | 2023-02-15 |
| PublicationDate_xml | – month: 02 year: 2023 text: 2023-02-15 day: 15 |
| PublicationDecade | 2020 |
| PublicationTitle | Journal of molecular structure |
| PublicationYear | 2023 |
| Publisher | Elsevier B.V |
| Publisher_xml | – name: Elsevier B.V |
| References | Chate (bib0006) 2018; 55 Lahmidi (bib0126) 2019; 1177 Poonia (bib0017) 2021; 21 Saadaoui (bib0125) 2019; 1180 Wong (bib0037) 2013; 45 Gadhave (bib0022) 2010 Thakkar (bib0099) 2017; 25 Chen (bib0038) 2016; 18 Pragathi (bib0140) 2021; 46 Strzelecka, Świątek (bib0014) 2021; 14 Przegaliński, Lewandowska (bib0056) 1979; 46 Mazur (bib0065) 2021 Bendaha (bib0091) 2011; 46 Muzaffar (bib0101) 2021; 107 Benson, Savell (bib0018) 1950; 46 Li (bib0142) 2020; 16 Bechara (bib0032) 2015; 17 Ram (bib0035) 2019 Miceli, Kauffman (bib0047) 2015; 61 Yang (bib0136) 2019; 92 Potts (bib0025) 1961; 61 Bera (bib0145) 2013; 67 Papeo, Pulici (bib0030) 2013; 18 Ali (bib0117) 2011; 68 Wu (bib0087) 2018; 143 Kerru (bib0001) 2020; 25 Liu, Molino Bruce, Nacro (bib0075) 2014 Pathak Ashish (bib0068) 2020 Özil, Balaydın, Şentürk (bib0144) 2019; 86 Hay, Dupont, Graybill (bib0042) 1987 Pogaku (bib0097) 2019; 29 Puthiyapurayil (bib0094) 2012; 57 Singh (bib0076) 2014 Sahu, Ganguly, Kaushik (bib0020) 2013; 11 Harris Joel, Neustadt Bernard, Stamford Andrew (bib0079) 2013 Paprocka (bib0107) 2015; 25 Hajlaoui (bib0130) 2021; 1237 Gogoi (bib0026) 2015; 80 Liu (bib0115) 2013; 21 Scharf (bib0053) 1990; 30 Haria, Fitton, McTavish (bib0055) 1994; 4 Liu (bib0008) 2019; 19 Hassan, Sarg, Hussein (bib0005) 2019; 56 Hofny (bib0084) 2021; 112 Torres (bib0046) 2005; 5 Dixit, Verma, Marwaha (bib0015) 2021; 18 Ohnishi (bib0057) 1981; 28 Yurttaş, CantŘrk (bib0088) 2018; 144 Richardson (bib0040) 1988; 544 Cao (bib0090) 2013; 24 Pibiri, Buscemi (bib0023) 2010; 6 Abu-Hashem, Al-Hussain (bib0132) 2022; 27 Ghannoum (bib0041) 1992; 36 Lv (bib0093) 2018; 22 Shahid (bib0102) 2021; 115 Zhang (bib0105) 2017; 27 Jubie (bib0113) 2012; 54 Sever (bib0129) 2021; 1224 Xu (bib0013) 2019; 180 Babb (bib0062) 2021 Schaub Richard, O`Hayer (bib0066) 2020 Xie (bib0089) 2017; 27 Czyrski (bib0019) 2021; 13 Huang, S., et al., 1,2,4-Triazolylaminoaryl (heteroaryl) sulfonamide derivatives. 2011, Janssen Pharmaceutica NV: US. Deng (bib0111) 2014; 73 Naaz (bib0134) 2020; 95 Lang (bib0002) 2020; 20 Shelke (bib0033) 2015; 26 Geria, Scheinfeld (bib0048) 2008; 11 Chen (bib0072) 2017 Perekhoda, L., et al., Synthesis and in silico antihypertensive activity prognosis of new Mannich bases containing the 1, 2, 4-triazole moiety. 2020. Santana (bib0009) 2020; 11 Patil (bib0098) 2017; 27 Sanad (bib0085) 2021; 31 Lee (bib0031) 2012; 68 Almasirad (bib0110) 2014; 22 Al-Mansury (bib0133) 2021; 55 Gomha, Farghaly, Sayed (bib0004) 2017; 54 Awad (bib0135) 2020; 96 Akın (bib0143) 2019; 1175 Bhat (bib0007) 2020; 57 Shalini (bib0021) 2011; 7 Zhang (bib0138) 2021; 218 Zhurilo (bib0100) 2018; 28 Jain, Piplani (bib0016) 2019; 19 Holota (bib0139) 2021; 26 Loustaud-Ratti (bib0049) 2016; 8 Khan (bib0141) 2020; 142 Jiang (bib0109) 2014; 12 Davis, Whittington, Bryson (bib0054) 1997; 53 Wellington, Plosker (bib0051) 2002; 62 Sarkar (bib0073) 2016 Perry (bib0050) 2010; 70 Saravolatz, Johnson, Kauffman (bib0043) 2003; 36 Yang (bib0137) 2020; 204 Castanedo (bib0034) 2011; 76 Brotherton-Pleiss Christine, E., et al., [1,2,4]triazolo[3,4-C][1,4]oxazines As P2×7 Modulators. 2014, Brotherton-Pleiss Christine E, Harris Iii Ralph New, Loe Bradley E, Lopez-Tapia Francisco Javier, Rege Pankaj D, Repke David Bruce, Stabler Russell Stephen, Walker Keith Adrian Murray, Roche Palo Alto LLC: US. Lingappa, Guruswamy, Bantal (bib0118) 2021; 10 Sanford, Plosker (bib0061) 2008; 68 Li (bib0080) 2013 Khan (bib0103) 2021; 39 Mohassab (bib0106) 2017; 75 Siddiqui (bib0116) 2011; 21 Sathyanarayana, Poojary (bib0024) 2020; 67 Bosch Jose, Moruno Ines (bib0082) 2012 Kumari (bib0095) 2021; 15 Tariq, Alam, Amir (bib0104) 2018; 351 Wiseman, Spencer (bib0060) 1997; 11 Bianco (bib0010) 2021; 14 Wang (bib0064) 2021 Huang, Wang (bib0067) 2020 Basappa (bib0127) 2020; 6 Nakka (bib0028) 2015; 47 Uemura (bib0052) 2015; 16 Henary (bib0003) 2020; 10 Luszczki, Plech, Wujec (bib0123) 2012; 690 Shakir (bib0124) 2021; 11 Dean David (bib0081) 2013 Sharma (bib0012) 2021; 26 Zveaghintseva (bib0086) 2021; 26 Bozkurt, Khan Firdos, Anil Seyda Tugba (bib0063) 2021 Herbrecht (bib0044) 2004; 58 Schiller, Fung (bib0045) 2007; 29 Zhang (bib0070) 2019 Yin (bib0039) 2009; 11 Jagerovic (bib0078) 2013 Kaproń (bib0121) 2020; 94 Ueda, Nagasawa (bib0036) 2009; 131 Shabalin, Camp (bib0011) 2020; 18 Dawson, Jue, Brogden (bib0058) 1984; 27 Huang (bib0029) 2015; 17 Mohamed (bib0096) 2018; 81 Muehlebach (bib0069) 2019 Fuh (bib0128) 2021; 114 Gani (bib0131) 2020; 32 Xu (bib0027) 2015; 80 Sarigol (bib0108) 2015; 23 Lamb, Adkins (bib0059) 1998; 56 Sari, Kaynak, Dalkara (bib0122) 2018; 70 Plech (bib0120) 2014; 86 Wu (bib0146) 2019; 29 Soerensen Ulrik (bib0074) 2014 Lankau (bib0071) 2017 Sekhar (bib0092) 2018; 145 Plech (bib0119) 2013; 60 Radhika, Venkatesham, Sarangapani (bib0112) 2012; 21 Schaub Richard (10.1016/j.molstruc.2022.134487_bib0066) 2020 Saravolatz (10.1016/j.molstruc.2022.134487_bib0043) 2003; 36 Wong (10.1016/j.molstruc.2022.134487_bib0037) 2013; 45 Papeo (10.1016/j.molstruc.2022.134487_bib0030) 2013; 18 Singh (10.1016/j.molstruc.2022.134487_bib0076) 2014 Plech (10.1016/j.molstruc.2022.134487_bib0119) 2013; 60 Gadhave (10.1016/j.molstruc.2022.134487_bib0022) 2010 Soerensen Ulrik (10.1016/j.molstruc.2022.134487_bib0074) 2014 Zveaghintseva (10.1016/j.molstruc.2022.134487_bib0086) 2021; 26 Akın (10.1016/j.molstruc.2022.134487_bib0143) 2019; 1175 Shakir (10.1016/j.molstruc.2022.134487_bib0124) 2021; 11 Ghannoum (10.1016/j.molstruc.2022.134487_bib0041) 1992; 36 Davis (10.1016/j.molstruc.2022.134487_bib0054) 1997; 53 Li (10.1016/j.molstruc.2022.134487_bib0142) 2020; 16 Özil (10.1016/j.molstruc.2022.134487_bib0144) 2019; 86 Khan (10.1016/j.molstruc.2022.134487_bib0103) 2021; 39 Wu (10.1016/j.molstruc.2022.134487_bib0146) 2019; 29 Chate (10.1016/j.molstruc.2022.134487_bib0006) 2018; 55 Scharf (10.1016/j.molstruc.2022.134487_bib0053) 1990; 30 Ali (10.1016/j.molstruc.2022.134487_bib0117) 2011; 68 Dawson (10.1016/j.molstruc.2022.134487_bib0058) 1984; 27 Paprocka (10.1016/j.molstruc.2022.134487_bib0107) 2015; 25 Khan (10.1016/j.molstruc.2022.134487_bib0141) 2020; 142 Wellington (10.1016/j.molstruc.2022.134487_bib0051) 2002; 62 Hajlaoui (10.1016/j.molstruc.2022.134487_bib0130) 2021; 1237 Cao (10.1016/j.molstruc.2022.134487_bib0090) 2013; 24 Puthiyapurayil (10.1016/j.molstruc.2022.134487_bib0094) 2012; 57 Bhat (10.1016/j.molstruc.2022.134487_bib0007) 2020; 57 Lamb (10.1016/j.molstruc.2022.134487_bib0059) 1998; 56 Awad (10.1016/j.molstruc.2022.134487_bib0135) 2020; 96 Sahu (10.1016/j.molstruc.2022.134487_bib0020) 2013; 11 Shabalin (10.1016/j.molstruc.2022.134487_bib0011) 2020; 18 Yurttaş (10.1016/j.molstruc.2022.134487_bib0088) 2018; 144 Benson (10.1016/j.molstruc.2022.134487_bib0018) 1950; 46 Potts (10.1016/j.molstruc.2022.134487_bib0025) 1961; 61 Xu (10.1016/j.molstruc.2022.134487_bib0027) 2015; 80 Bozkurt (10.1016/j.molstruc.2022.134487_bib0063) 2021 Poonia (10.1016/j.molstruc.2022.134487_bib0017) 2021; 21 Ueda (10.1016/j.molstruc.2022.134487_bib0036) 2009; 131 Zhang (10.1016/j.molstruc.2022.134487_bib0105) 2017; 27 Jubie (10.1016/j.molstruc.2022.134487_bib0113) 2012; 54 Sharma (10.1016/j.molstruc.2022.134487_bib0012) 2021; 26 Almasirad (10.1016/j.molstruc.2022.134487_bib0110) 2014; 22 Uemura (10.1016/j.molstruc.2022.134487_bib0052) 2015; 16 Lv (10.1016/j.molstruc.2022.134487_bib0093) 2018; 22 Yin (10.1016/j.molstruc.2022.134487_bib0039) 2009; 11 Siddiqui (10.1016/j.molstruc.2022.134487_bib0116) 2011; 21 Sarigol (10.1016/j.molstruc.2022.134487_bib0108) 2015; 23 Sathyanarayana (10.1016/j.molstruc.2022.134487_bib0024) 2020; 67 Torres (10.1016/j.molstruc.2022.134487_bib0046) 2005; 5 Wiseman (10.1016/j.molstruc.2022.134487_bib0060) 1997; 11 Pragathi (10.1016/j.molstruc.2022.134487_bib0140) 2021; 46 Huang (10.1016/j.molstruc.2022.134487_bib0029) 2015; 17 Sanad (10.1016/j.molstruc.2022.134487_bib0085) 2021; 31 Dixit (10.1016/j.molstruc.2022.134487_bib0015) 2021; 18 Lee (10.1016/j.molstruc.2022.134487_bib0031) 2012; 68 Przegaliński (10.1016/j.molstruc.2022.134487_bib0056) 1979; 46 Hay (10.1016/j.molstruc.2022.134487_bib0042) 1987 Naaz (10.1016/j.molstruc.2022.134487_bib0134) 2020; 95 Saadaoui (10.1016/j.molstruc.2022.134487_bib0125) 2019; 1180 Perry (10.1016/j.molstruc.2022.134487_bib0050) 2010; 70 10.1016/j.molstruc.2022.134487_bib0077 Liu (10.1016/j.molstruc.2022.134487_bib0008) 2019; 19 Gomha (10.1016/j.molstruc.2022.134487_bib0004) 2017; 54 Radhika (10.1016/j.molstruc.2022.134487_bib0112) 2012; 21 10.1016/j.molstruc.2022.134487_bib0114 Bendaha (10.1016/j.molstruc.2022.134487_bib0091) 2011; 46 Mohassab (10.1016/j.molstruc.2022.134487_bib0106) 2017; 75 Yang (10.1016/j.molstruc.2022.134487_bib0136) 2019; 92 Czyrski (10.1016/j.molstruc.2022.134487_bib0019) 2021; 13 Li (10.1016/j.molstruc.2022.134487_bib0080) 2013 Kaproń (10.1016/j.molstruc.2022.134487_bib0121) 2020; 94 Gani (10.1016/j.molstruc.2022.134487_bib0131) 2020; 32 Bechara (10.1016/j.molstruc.2022.134487_bib0032) 2015; 17 Zhang (10.1016/j.molstruc.2022.134487_bib0070) 2019 Yang (10.1016/j.molstruc.2022.134487_bib0137) 2020; 204 Schiller (10.1016/j.molstruc.2022.134487_bib0045) 2007; 29 Bianco (10.1016/j.molstruc.2022.134487_bib0010) 2021; 14 Richardson (10.1016/j.molstruc.2022.134487_bib0040) 1988; 544 Mazur (10.1016/j.molstruc.2022.134487_bib0065) 2021 10.1016/j.molstruc.2022.134487_bib0083 Wang (10.1016/j.molstruc.2022.134487_bib0064) 2021 Zhurilo (10.1016/j.molstruc.2022.134487_bib0100) 2018; 28 Liu (10.1016/j.molstruc.2022.134487_bib0115) 2013; 21 Strzelecka (10.1016/j.molstruc.2022.134487_bib0014) 2021; 14 Bosch Jose (10.1016/j.molstruc.2022.134487_bib0082) 2012 Chen (10.1016/j.molstruc.2022.134487_bib0038) 2016; 18 Lang (10.1016/j.molstruc.2022.134487_bib0002) 2020; 20 Sarkar (10.1016/j.molstruc.2022.134487_bib0073) 2016 Bera (10.1016/j.molstruc.2022.134487_bib0145) 2013; 67 Loustaud-Ratti (10.1016/j.molstruc.2022.134487_bib0049) 2016; 8 Basappa (10.1016/j.molstruc.2022.134487_bib0127) 2020; 6 Jain (10.1016/j.molstruc.2022.134487_bib0016) 2019; 19 Gogoi (10.1016/j.molstruc.2022.134487_bib0026) 2015; 80 Jagerovic (10.1016/j.molstruc.2022.134487_bib0078) 2013 Chen (10.1016/j.molstruc.2022.134487_bib0072) 2017 Lingappa (10.1016/j.molstruc.2022.134487_bib0118) 2021; 10 Kerru (10.1016/j.molstruc.2022.134487_bib0001) 2020; 25 Sanford (10.1016/j.molstruc.2022.134487_bib0061) 2008; 68 Shahid (10.1016/j.molstruc.2022.134487_bib0102) 2021; 115 Jiang (10.1016/j.molstruc.2022.134487_bib0109) 2014; 12 Pibiri (10.1016/j.molstruc.2022.134487_bib0023) 2010; 6 Liu (10.1016/j.molstruc.2022.134487_bib0075) 2014 Zhang (10.1016/j.molstruc.2022.134487_bib0138) 2021; 218 Xu (10.1016/j.molstruc.2022.134487_bib0013) 2019; 180 Abu-Hashem (10.1016/j.molstruc.2022.134487_bib0132) 2022; 27 Xie (10.1016/j.molstruc.2022.134487_bib0089) 2017; 27 Patil (10.1016/j.molstruc.2022.134487_bib0098) 2017; 27 Huang (10.1016/j.molstruc.2022.134487_bib0067) 2020 Henary (10.1016/j.molstruc.2022.134487_bib0003) 2020; 10 Muehlebach (10.1016/j.molstruc.2022.134487_bib0069) 2019 Muzaffar (10.1016/j.molstruc.2022.134487_bib0101) 2021; 107 Nakka (10.1016/j.molstruc.2022.134487_bib0028) 2015; 47 Shelke (10.1016/j.molstruc.2022.134487_bib0033) 2015; 26 Tariq (10.1016/j.molstruc.2022.134487_bib0104) 2018; 351 Ram (10.1016/j.molstruc.2022.134487_bib0035) 2019 Herbrecht (10.1016/j.molstruc.2022.134487_bib0044) 2004; 58 Miceli (10.1016/j.molstruc.2022.134487_bib0047) 2015; 61 Haria (10.1016/j.molstruc.2022.134487_bib0055) 1994; 4 Al-Mansury (10.1016/j.molstruc.2022.134487_bib0133) 2021; 55 Sekhar (10.1016/j.molstruc.2022.134487_bib0092) 2018; 145 Hassan (10.1016/j.molstruc.2022.134487_bib0005) 2019; 56 Lahmidi (10.1016/j.molstruc.2022.134487_bib0126) 2019; 1177 Kumari (10.1016/j.molstruc.2022.134487_bib0095) 2021; 15 Babb (10.1016/j.molstruc.2022.134487_bib0062) 2021 Sari (10.1016/j.molstruc.2022.134487_bib0122) 2018; 70 Sever (10.1016/j.molstruc.2022.134487_bib0129) 2021; 1224 Geria (10.1016/j.molstruc.2022.134487_bib0048) 2008; 11 Luszczki (10.1016/j.molstruc.2022.134487_bib0123) 2012; 690 Harris Joel (10.1016/j.molstruc.2022.134487_bib0079) 2013 Shalini (10.1016/j.molstruc.2022.134487_bib0021) 2011; 7 Holota (10.1016/j.molstruc.2022.134487_bib0139) 2021; 26 Mohamed (10.1016/j.molstruc.2022.134487_bib0096) 2018; 81 Plech (10.1016/j.molstruc.2022.134487_bib0120) 2014; 86 Castanedo (10.1016/j.molstruc.2022.134487_bib0034) 2011; 76 Deng (10.1016/j.molstruc.2022.134487_bib0111) 2014; 73 Dean David (10.1016/j.molstruc.2022.134487_bib0081) 2013 Lankau (10.1016/j.molstruc.2022.134487_bib0071) 2017 Hofny (10.1016/j.molstruc.2022.134487_bib0084) 2021; 112 Pogaku (10.1016/j.molstruc.2022.134487_bib0097) 2019; 29 Santana (10.1016/j.molstruc.2022.134487_bib0009) 2020; 11 Fuh (10.1016/j.molstruc.2022.134487_bib0128) 2021; 114 Pathak Ashish (10.1016/j.molstruc.2022.134487_bib0068) 2020 Ohnishi (10.1016/j.molstruc.2022.134487_bib0057) 1981; 28 Wu (10.1016/j.molstruc.2022.134487_bib0087) 2018; 143 Thakkar (10.1016/j.molstruc.2022.134487_bib0099) 2017; 25 |
| References_xml | – year: 2019 ident: bib0069 article-title: Pesticidally Active 1,2,4-Triazole Derivatives With Sulphur Containing Substituents – volume: 19 start-page: 1517 year: 2019 end-page: 1530 ident: bib0008 article-title: A review on the antitumor activity of various nitrogenous-based heterocyclic compounds as NSCLC inhibitors publication-title: Mini Rev. Med. Chem. – volume: 68 start-page: 2045 year: 2012 end-page: 2051 ident: bib0031 article-title: Synthesis of 1, 3, 5-trisubstituted-1, 2, 4-triazoles by microwave-assisted N-acylation of amide derivatives and the consecutive reaction with hydrazine hydrochlorides publication-title: Tetrahedron – volume: 61 start-page: 1558 year: 2015 end-page: 1565 ident: bib0047 article-title: Isavuconazole: a new broad-spectrum triazole antifungal agent publication-title: Clinic. Infect. Dis. – volume: 19 start-page: 1298 year: 2019 end-page: 1368 ident: bib0016 article-title: Exploring the chemistry and therapeutic potential of triazoles: a comprehensive literature review publication-title: Mini Rev. Med. Chem. – volume: 81 start-page: 599 year: 2018 end-page: 611 ident: bib0096 article-title: Synthesis, antimicrobial activity and molecular modeling study of 3-(5-amino-(2H)-1, 2, 4-triazol-3-yl]-naphthyridinones as potential DNA-gyrase inhibitors publication-title: Bioorg. Chem. – volume: 54 start-page: 931 year: 2012 end-page: 935 ident: bib0113 article-title: Synthesis, antidepressant and antimicrobial activities of some novel stearic acid analogues publication-title: Eur. J. Med. Chem. – volume: 29 start-page: 383 year: 2019 end-page: 388 ident: bib0146 article-title: Synthesis, biological evaluation and 3D-QSAR studies of 1, 2, 4-triazole-5-substituted carboxylic acid bioisosteres as uric acid transporter 1 (URAT1) inhibitors for the treatment of hyperuricemia associated with gout publication-title: Bioorg. Med. Chem. Lett. – volume: 131 start-page: 15080 year: 2009 end-page: 15081 ident: bib0036 article-title: Facile synthesis of 1, 2, 4-triazoles via a copper-catalyzed tandem addition− oxidative cyclization publication-title: J. Am. Chem. Soc. – volume: 27 start-page: 2171 year: 2017 end-page: 2173 ident: bib0089 article-title: Design, synthesis, and publication-title: Bioorg. Med. Chem. Lett. – volume: 56 start-page: 1437 year: 2019 end-page: 1457 ident: bib0005 article-title: Design, synthesis, and anticancer activity of novel benzothiazole analogues publication-title: J. Heterocycl. Chem. – year: 2021 ident: bib0062 article-title: Anti-SARS-CoV-2-Spike Glycoprotein Antibodies and Antigen-Binding Fragments – volume: 12 start-page: 2114 year: 2014 end-page: 2127 ident: bib0109 article-title: Discovery of potential anti-inflammatory drugs: diaryl-1, 2, 4-triazoles bearing N-hydroxyurea moiety as dual inhibitors of cyclooxygenase-2 and 5-lipoxygenase publication-title: Org. Biomol. Chem. – volume: 112 year: 2021 ident: bib0084 article-title: Design, synthesis, and antibacterial evaluation of new quinoline-1, 3, 4-oxadiazole and quinoline-1, 2, 4-triazole hybrids as potential inhibitors of DNA gyrase and topoisomerase IV publication-title: Bioorg. Chem. – volume: 8 start-page: 123 year: 2016 ident: bib0049 article-title: Ribavirin: past, present and future publication-title: World J. Hepatol. – volume: 67 start-page: 325 year: 2013 end-page: 334 ident: bib0145 article-title: A structure–activity relationship study of 1, 2, 4-triazolo [1, 5-a][1, 3, 5] triazin-5, 7-dione and its 5-thioxo analogues on anti-thymidine phosphorylase and associated anti-angiogenic activities publication-title: Eur. J. Medicin. Chem. – reference: Brotherton-Pleiss Christine, E., et al., [1,2,4]triazolo[3,4-C][1,4]oxazines As P2×7 Modulators. 2014, Brotherton-Pleiss Christine E, Harris Iii Ralph New, Loe Bradley E, Lopez-Tapia Francisco Javier, Rege Pankaj D, Repke David Bruce, Stabler Russell Stephen, Walker Keith Adrian Murray, Roche Palo Alto LLC: US. – volume: 5 start-page: 775 year: 2005 end-page: 785 ident: bib0046 article-title: Posaconazole: a broad-spectrum triazole antifungal publication-title: Lancet Infect. Dis. – year: 2013 ident: bib0081 article-title: 5,6,7,8-Tetrahydro[1,2,4]Triazolo[4,3-a]Pyrazine Derivatives As P2×7 Modulators – volume: 25 start-page: 2664 year: 2015 end-page: 2667 ident: bib0107 article-title: Synthesis and anti-inflammatory activity of new 1, 2, 4-triazole derivatives publication-title: Bioorg. Med. Chem. Lett. – volume: 80 start-page: 1789 year: 2015 end-page: 1794 ident: bib0027 article-title: Copper-catalyzed one-pot synthesis of 1, 2, 4-triazoles from nitriles and hydroxylamine publication-title: J. Org. Chem. – volume: 10 start-page: 14170 year: 2020 end-page: 14197 ident: bib0003 article-title: Benefits and applications of microwave-assisted synthesis of nitrogen containing heterocycles in medicinal chemistry publication-title: RSC Adv. – volume: 55 start-page: 2297 year: 2018 end-page: 2302 ident: bib0006 article-title: Design, synthesis and SAR study of novel spiro [Pyrimido [5, 4-b] Quinoline-10, 5′-Pyrrolo [2, 3-d] Pyrimidine] derivatives as promising anticancer agents publication-title: J. Heterocycl. Chem. – year: 2021 ident: bib0065 article-title: Substituted Amino Triazoles Useful as Chitinase Inhibitors – volume: 27 start-page: 3845 year: 2017 end-page: 3850 ident: bib0098 article-title: Antileishmanial potential of fused 5-(pyrazin-2-yl)-4H-1, 2, 4-triazole-3-thiols: synthesis, biological evaluations and computational studies publication-title: Bioorg. Med. Chem. Lett. – volume: 1175 start-page: 280 year: 2019 end-page: 286 ident: bib0143 article-title: Synthesis, biological activities and molecular docking studies of some novel 2, 4, 5-trisubstituted-1, 2, 4-triazole-3-one derivatives as potent tyrosinase inhibitors publication-title: J. Mol. Struct. – year: 2020 ident: bib0068 article-title: 4-Substituted-2-Thiazole Amides as Antiviral Agents – volume: 6 start-page: e05290 year: 2020 ident: bib0127 article-title: Design and synthesis of coumarin-triazole hybrids: biocompatible anti-diabetic agents, in silico molecular docking and ADME screening publication-title: Heliyon – year: 2013 ident: bib0079 article-title: Substituted [1,2,4]triazolo[4,3-alpha]quinoxalines As Adenosine A2a Receptor Antagonists – volume: 27 start-page: 835 year: 2022 ident: bib0132 article-title: Design, synthesis of new 1, 2, 4-triazole/1, 3, 4-thiadiazole with spiroindoline, imidazo [4, 5-b] quinoxaline and thieno [2, 3-d] pyrimidine from isatin derivatives as anticancer agents publication-title: Molecules – volume: 45 start-page: 1083 year: 2013 end-page: 1093 ident: bib0037 article-title: A Safe Synthesis of 1, 5-Disubstituted 3-Amino-1H-1, 2, 4-triazoles from 1, 3, 4-Oxadiazolium Hexafluorophosphates publication-title: Synthesis – year: 2014 ident: bib0074 article-title: Substituted [1,2,4]triazolo[1,5- – volume: 107 year: 2021 ident: bib0101 article-title: Probing phenylcarbamoylazinane-1, 2, 4-triazole amides derivatives as lipoxygenase inhibitors along with cytotoxic, ADME and molecular docking studies publication-title: Bioorg. Chem. – volume: 544 start-page: 4 year: 1988 end-page: 11 ident: bib0040 article-title: Design and evaluation of a systemically active agent, fluconazole publication-title: Ann. N. Y. Acad. Sci. – volume: 21 start-page: 1023 year: 2011 end-page: 1026 ident: bib0116 article-title: Triazole incorporated pyridazinones as a new class of antihypertensive agents: design, synthesis and publication-title: Bioorg. Med. Chem. Lett. – volume: 22 start-page: 1 year: 2014 end-page: 8 ident: bib0110 article-title: Synthesis, analgesic and anti-inflammatory activities of new methyl-imidazolyl-1, 3, 4-oxadiazoles and 1, 2, 4-triazoles publication-title: Daru J. Pharm. Sci. – volume: 17 start-page: 2894 year: 2015 end-page: 2897 ident: bib0029 article-title: Copper-catalyzed oxidative C (sp3)–H functionalization for facile synthesis of 1, 2, 4-triazoles and 1, 3, 5-triazines from amidines publication-title: Org. Lett. – reference: Perekhoda, L., et al., Synthesis and in silico antihypertensive activity prognosis of new Mannich bases containing the 1, 2, 4-triazole moiety. 2020. – volume: 23 start-page: 2518 year: 2015 end-page: 2528 ident: bib0108 article-title: Novel thiazolo [3, 2-b]-1, 2, 4-triazoles derived from naproxen with analgesic/anti-inflammatory properties: synthesis, biological evaluation and molecular modeling studies publication-title: Bioorg. Med. Chem. – volume: 10 start-page: 33 year: 2021 end-page: 42 ident: bib0118 article-title: Synthesis and characterization of 4-amino-4H-1, 2, 4-triazole derivatives: anticonvulsant activity publication-title: Curr. Chem. Lett. – volume: 26 start-page: 404 year: 2015 end-page: 407 ident: bib0033 article-title: Microwave-assisted catalyst-free synthesis of substituted 1, 2, 4-triazoles publication-title: Synlett – volume: 60 start-page: 208 year: 2013 end-page: 215 ident: bib0119 article-title: Synthesis, characterization and preliminary anticonvulsant evaluation of some 4-alkyl-1, 2, 4-triazoles publication-title: Eur. J. Med. Chem. – volume: 18 start-page: 3950 year: 2020 end-page: 3964 ident: bib0011 article-title: Recent advances in the synthesis of imidazoles publication-title: Org. Biomol. Chem. – year: 2014 ident: bib0076 article-title: Bridged Bicyclic Heteroaryl Substituted Triazoles Useful As Axl inhibitors – volume: 145 start-page: 1 year: 2018 end-page: 10 ident: bib0092 article-title: Synthesis and antimicrobial activity of pyrimidinyl 1, 3, 4-oxadiazoles, 1, 3, 4-thiadiazoles and 1, 2, 4-triazoles publication-title: Eur. J. Med. Chem. – volume: 11 start-page: 501 year: 2021 end-page: 511 ident: bib0124 article-title: Synthesis, antioxidant activity and molecular docking study of 1, 2, 4-triazole and their corresponding fused rings containing 2-methylphenol publication-title: Drug Deliv. – volume: 27 start-page: 132 year: 1984 end-page: 147 ident: bib0058 article-title: Alprazolam publication-title: Drugs – volume: 11 start-page: 5482 year: 2009 end-page: 5485 ident: bib0039 article-title: Highly efficient cyanoimidation of aldehydes publication-title: Org. Lett. – year: 2020 ident: bib0067 article-title: Pyrazolopyridines and Triazolopyridines as A2A /A2B Inhibitors – volume: 70 start-page: 1116 year: 2018 end-page: 1123 ident: bib0122 article-title: Synthesis and anticonvulsant screening of 1, 2, 4-triazole derivatives publication-title: Pharmacol. Rep. – year: 2017 ident: bib0072 article-title: Triazole Agonists of the APJ Receptor – year: 2013 ident: bib0080 article-title: Substituted [1,2,4]triazolo[4,3-A]pyrazine 11-beta-hydroxysteroid Dehydrogenase Inhibitors – volume: 68 start-page: 1319 year: 2008 end-page: 1340 ident: bib0061 article-title: Anastrozole publication-title: Drugs – volume: 24 start-page: 303 year: 2013 end-page: 306 ident: bib0090 article-title: Design and synthesis of novel antifungal triazole derivatives with good activity and water solubility publication-title: Chin. Chem. Lett. – volume: 94 year: 2020 ident: bib0121 article-title: Preclinical evaluation of 1, 2, 4-triazole-based compounds targeting voltage-gated sodium channels (VGSCs) as promising anticonvulsant drug candidates publication-title: Bioorg. Chem. – volume: 46 start-page: 1 year: 1950 end-page: 68 ident: bib0018 article-title: The chemistry of the vicinal triazoles publication-title: Chem. Rev. – volume: 76 start-page: 1177 year: 2011 end-page: 1179 ident: bib0034 article-title: Rapid synthesis of 1, 3, 5-substituted 1, 2, 4-triazoles from carboxylic acids, amidines, and hydrazines publication-title: J. Org. Chem. – volume: 20 start-page: 2150 year: 2020 end-page: 2168 ident: bib0002 article-title: Nitrogen-containing heterocycles as anticancer agents: an overview publication-title: Anti-Cancer Agents Medicin. Chem. – volume: 75 start-page: 242 year: 2017 end-page: 259 ident: bib0106 article-title: Novel quinoline incorporating 1, 2, 4-triazole/oxime hybrids: synthesis, molecular docking, anti-inflammatory, COX inhibition, ulceroginicity and histopathological investigations publication-title: Bioorg. Chem. – volume: 62 start-page: 1539 year: 2002 end-page: 1574 ident: bib0051 article-title: Rizatriptan publication-title: Drugs – volume: 92 year: 2019 ident: bib0136 article-title: Novel [1, 2, 4] triazolo [1, 5-a] pyrimidine derivatives as potent antitubulin agents: design, multicomponent synthesis and antiproliferative activities publication-title: Bioorg. Chem. – volume: 46 start-page: 303 year: 1979 end-page: 312 ident: bib0056 article-title: The effect of etoperidone, a new potential antidepressant drug, on the central serotonin system publication-title: J. Neural Transm. – volume: 26 start-page: 1 year: 2021 end-page: 21 ident: bib0086 article-title: Chromenol derivatives as novel antifungal agents: synthesis, in silico and in vitro evaluation publication-title: Molecules – volume: 26 start-page: 4213 year: 2021 ident: bib0012 article-title: Imidazoles as potential anticancer agents: an update on recent studies publication-title: Molecules – volume: 86 start-page: 690 year: 2014 end-page: 699 ident: bib0120 article-title: Studies on the anticonvulsant activity of 4-alkyl-1, 2, 4-triazole-3-thiones and their effect on GABAergic system publication-title: Eur. J. Med. Chem. – volume: 29 start-page: 1682 year: 2019 end-page: 1687 ident: bib0097 article-title: Ultrasonication-ionic liquid synergy for the synthesis of new potent anti-tuberculosis 1, 2, 4-triazol-1-yl-pyrazole based spirooxindolopyrrolizidines publication-title: Bioorg. Med. Chem. Lett. – volume: 29 start-page: 1862 year: 2007 end-page: 1886 ident: bib0045 article-title: Posaconazole: an extended-spectrum triazole antifungal agent publication-title: Clin. Ther. – start-page: 82 year: 2010 end-page: 89 ident: bib0022 article-title: Current biological and synthetic profile of triazoles: a review publication-title: Annals Biol. Res – volume: 18 start-page: 1334 year: 2016 end-page: 1337 ident: bib0038 article-title: I2-catalyzed oxidative coupling reactions of hydrazones and amines and the application in the synthesis of 1, 3, 5-trisubstituted 1, 2, 4-triazoles publication-title: Org. Lett. – volume: 55 start-page: 556 year: 2021 end-page: 565 ident: bib0133 article-title: Synthesis, antiproliferative and antioxidant activity of 3-mercapto-1, 2, 4-triazole derivatives as combretastatin A-4 analogues publication-title: Pharm. Chem. J. – volume: 54 start-page: 1537 year: 2017 end-page: 1542 ident: bib0004 article-title: Design, synthesis, and characterization of some new bis-thiazoles publication-title: J. Heterocycl. Chem. – volume: 1237 year: 2021 ident: bib0130 article-title: Novel pyrano-triazolo-pyrimidine derivatives as anti- α-amylase agents: synthesis, molecular docking investigations and computational analysis publication-title: J. Mol. Struct. – volume: 56 start-page: 1125 year: 1998 end-page: 1140 ident: bib0059 article-title: Letrozole publication-title: Drugs – volume: 57 start-page: 390 year: 2020 end-page: 399 ident: bib0007 article-title: Design, synthesis, anticancer, antibacterial, and antifungal evaluation of 4-aminoquinoline-1, 3, 5-triazine derivatives publication-title: J. Heterocycl. Chem. – volume: 4 start-page: 331 year: 1994 end-page: 355 ident: bib0055 article-title: Trazodone publication-title: Drugs Aging – volume: 73 start-page: 217 year: 2014 end-page: 224 ident: bib0111 article-title: Design, synthesis and evaluation of the antidepressant and anticonvulsant activities of triazole-containing quinolinones publication-title: Eur. J. Med. Chem. – volume: 28 start-page: 1641 year: 1981 end-page: 1646 ident: bib0057 article-title: A new approach to the treatment of atherosclerosis and trapidil as an antagonist to platelet-derived growth factor publication-title: Life Sci. – volume: 14 start-page: 224 year: 2021 ident: bib0014 article-title: 1, 2, 4-Triazoles as important antibacterial agents publication-title: Pharmaceuticals – year: 2019 ident: bib0035 article-title: The Chemistry of Heterocycles: Chemistry of Six to Eight Membered N, O, S, P and Se Heterocycles – volume: 144 start-page: 255 year: 2018 end-page: 261 ident: bib0088 article-title: The synthesis, antifungal and apoptotic effects of triazole-oxadiazoles against Candida species publication-title: Eur. J. Med. Chem. – volume: 114 year: 2021 ident: bib0128 article-title: Design, synthesis and biological evaluation of glycolamide, glycinamide, and β-amino carbonyl 1, 2, 4-triazole derivatives as DPP-4 inhibitors publication-title: Bioorg. Chem. – volume: 58 start-page: 612 year: 2004 end-page: 624 ident: bib0044 article-title: Posaconazole: a potent, extended-spectrum triazole anti-fungal for the treatment of serious fungal infections publication-title: Int. J. Clin. Pract. – volume: 95 year: 2020 ident: bib0134 article-title: Design and synthesis of newer 1, 3, 4-oxadiazole and 1, 2, 4-triazole based Topsentin analogues as anti-proliferative agent targeting tubulin publication-title: Bioorg. Chem. – volume: 16 start-page: 119 year: 2020 end-page: 127 ident: bib0142 article-title: Synthesis and biological evaluation of 5-benzyl-3-pyridyl-1H-1, 2, 4-triazole derivatives as xanthine oxidase inhibitors publication-title: Med. Chem. – reference: Huang, S., et al., 1,2,4-Triazolylaminoaryl (heteroaryl) sulfonamide derivatives. 2011, Janssen Pharmaceutica NV: US. – volume: 53 start-page: 608 year: 1997 end-page: 636 ident: bib0054 article-title: Nefazodone publication-title: Drugs – volume: 690 start-page: 99 year: 2012 end-page: 106 ident: bib0123 article-title: Effect of 4-(4-bromophenyl)-5-(3-chlorophenyl)-2, 4-dihydro-3H-1, 2, 4-triazole-3-thione on the anticonvulsant action of different classical antiepileptic drugs in the mouse maximal electroshock-induced seizure model publication-title: Eur. J. Pharmacol. – volume: 218 year: 2021 ident: bib0138 article-title: Identification of novel 1, 3-diaryl-1, 2, 4-triazole-capped histone deacetylase 6 inhibitors with potential anti-gastric cancer activity publication-title: Eur. J. Med. Chem. – volume: 36 start-page: 630 year: 2003 end-page: 637 ident: bib0043 article-title: Voriconazole: a new triazole antifungal agent publication-title: Clinic. Infect. Dis. – volume: 142 start-page: 345 year: 2020 end-page: 354 ident: bib0141 article-title: Exploring biological efficacy of coumarin clubbed thiazolo [3, 2–b][1, 2, 4] triazoles as efficient inhibitors of urease: a biochemical and in silico approach publication-title: Int. J. Biol. Macromol. – volume: 61 start-page: 87 year: 1961 end-page: 127 ident: bib0025 article-title: The chemistry of 1, 2, 4-triazoles publication-title: Chem. Rev. – volume: 11 start-page: 456 year: 2013 end-page: 465 ident: bib0020 article-title: Triazoles: a valuable insight into recent developments and biological activities publication-title: Chin. J. Nat. Med. – volume: 25 start-page: 4064 year: 2017 end-page: 4075 ident: bib0099 article-title: 1, 2, 4-Triazole and 1, 3, 4-oxadiazole analogues: synthesis, MO studies, in silico molecular docking studies, antimalarial as DHFR inhibitor and antimicrobial activities publication-title: Bioorg. Med. Chem. – volume: 96 year: 2020 ident: bib0135 article-title: Structure-based design and optimization of pyrimidine-and 1, 2, 4-triazolo [4, 3-a] pyrimidine-based matrix metalloproteinase-10/13 inhibitors via Dimroth rearrangement towards targeted polypharmacology publication-title: Bioorg. Chem. – year: 2012 ident: bib0082 article-title: New 7-Phenyl-[1,2,4]Triazolo[4,3-a]Pyridin-3(2H)-One Derivatives – volume: 26 start-page: 1162 year: 2021 ident: bib0139 article-title: Synthesis, characterization and in vitro evaluation of novel 5-ene-thiazolo [3, 2-b][1, 2, 4] triazole-6 (5 h)-ones as possible anticancer agents publication-title: Molecules – start-page: S1 year: 1987 end-page: S3 ident: bib0042 article-title: First international symposium on itraconazole: a summary publication-title: Rev. Infect. Dis. – volume: 16 start-page: 1395 year: 2015 end-page: 1402 ident: bib0052 article-title: Residual effects of zolpidem, triazolam, rilmazafone and placebo in healthy elderly subjects: a randomized double-blind study publication-title: Sleep Med. – volume: 39 start-page: 457 year: 2021 end-page: 475 ident: bib0103 article-title: Synthesis, characterization and anti-inflammatory activity evaluation of 1, 2, 4-triazole and its derivatives as a potential scaffold for the synthesis of drugs against prostaglandin-endoperoxide synthase publication-title: J. Biomol. Struct. Dyn. – volume: 13 start-page: 1961 year: 2021 ident: bib0019 article-title: The overview on the pharmacokinetic and pharmacodynamic interactions of triazoles publication-title: Pharmaceutics – year: 2021 ident: bib0064 article-title: Combination Therapy Comprising A2A/A2B and PD-1/PD-L1 Inhibitors – volume: 143 start-page: 1840 year: 2018 end-page: 1846 ident: bib0087 article-title: Molecular docking, design, synthesis and antifungal activity study of novel triazole derivatives publication-title: Eur. J. Med. Chem. – volume: 31 start-page: 370 year: 2021 end-page: 372 ident: bib0085 article-title: New thieno [2, 3-b] pyridine-fused [1, 2, 4] triazolo [4, 3-a] pyrimidinone hybrids as potential MRSA and VRE inhibitors publication-title: Mendeleev Commun. – volume: 70 start-page: 1189 year: 2010 end-page: 1213 ident: bib0050 article-title: Maraviroc publication-title: Drugs – volume: 57 start-page: 407 year: 2012 end-page: 416 ident: bib0094 article-title: Synthesis, spectral characterization and biological evaluation of a novel series of 6-arylsubstituted-3-[2-(4-substitutedphenyl) propan-2-yl]-7H-[1, 2, 4] triazolo [3, 4-b][1, 3, 4] thiadiazines publication-title: Eur. J. Med. Chem. – year: 2016 ident: bib0073 article-title: 1, 2, 4-triazole Derivatives and Their Anti-Microbial Activity – volume: 25 start-page: 1909 year: 2020 ident: bib0001 article-title: A review on recent advances in nitrogen-containing molecules and their biological applications publication-title: Molecules – volume: 180 start-page: 656 year: 2019 end-page: 672 ident: bib0013 article-title: Triazole derivatives as inhibitors of Alzheimer's disease: current developments and structure-activity relationships publication-title: Eur. J. Med. Chem. – volume: 15 start-page: 1 year: 2021 end-page: 16 ident: bib0095 article-title: Synthesis and biological evaluation of heterocyclic 1, 2, 4-triazole scaffolds as promising pharmacological agents publication-title: BMC Chem. – volume: 36 start-page: 2239 year: 1992 end-page: 2244 ident: bib0041 article-title: Modulation of interactions of Candida albicans and endothelial cells by fluconazole and amphotericin B publication-title: Antimicrob. Agents Chemother. – volume: 46 start-page: 4117 year: 2011 end-page: 4124 ident: bib0091 article-title: New azole antifungal agents with novel modes of action: synthesis and biological studies of new tridentate ligands based on pyrazole and triazole publication-title: Eur. J. Med. Chem. – year: 2019 ident: bib0070 article-title: Method of Synthesizing 1,2,4-Triazole-3-Thione Compounds And Intermediates Thereof – volume: 32 start-page: 3388 year: 2020 end-page: 3399 ident: bib0131 article-title: Synthesis of novel indole, 1,2,4-triazole derivatives as potential glucosidase inhibitors publication-title: J. King Saud Univ. – volume: 351 year: 2018 ident: bib0104 article-title: Synthesis, p38α MAP kinase inhibition, anti-inflammatory activity, and molecular docking studies of 1, 2, 4-triazole-based benzothiazole-2-amines publication-title: Arch. Pharm. – volume: 21 start-page: 7742 year: 2013 end-page: 7751 ident: bib0115 article-title: Design, synthesis, and biological evaluation of 1, 2, 4-triazole bearing 5-substituted biphenyl-2-sulfonamide derivatives as potential antihypertensive candidates publication-title: Bioorg. Med. Chem. – year: 2017 ident: bib0071 article-title: (1,2,4)Triazolo[4,3-A]Quinoxaline Derivatives As Inhibitors of Phosphodiesterases – volume: 7 start-page: 668 year: 2011 end-page: 677 ident: bib0021 article-title: Advances in synthetic approach to and antifungal activity of triazoles publication-title: Beilstein J. Org. Chem. – volume: 67 start-page: 459 year: 2020 end-page: 477 ident: bib0024 article-title: Exploring recent developments on 1, 2, 4-triazole: synthesis and biological applications publication-title: J. Chin. Chem. Soc. – volume: 27 start-page: 4409 year: 2017 end-page: 4414 ident: bib0105 article-title: Design, synthesis, anti-inflammatory activity, and molecular docking studies of perimidine derivatives containing triazole publication-title: Bioorg. Med. Chem. Lett. – year: 2021 ident: bib0063 article-title: Anti-cancer Azole Compounds – volume: 17 start-page: 1184 year: 2015 end-page: 1187 ident: bib0032 article-title: One-pot synthesis of 3, 4, 5-trisubstituted 1, 2, 4-triazoles via the addition of hydrazides to activated secondary amides publication-title: Org. Lett. – volume: 115 year: 2021 ident: bib0102 article-title: Exploring phenylcarbamoylazinane-1, 2, 4-triazole thioethers as lipoxygenase inhibitors supported with publication-title: Bioorg. Chem. – volume: 18 start-page: 2535 year: 2021 end-page: 2565 ident: bib0015 article-title: A review on ‘triazoles’: their chemistry, synthesis and pharmacological potentials publication-title: J. Iran. Chem. Soc. – volume: 22 start-page: 101 year: 2018 end-page: 109 ident: bib0093 article-title: Synthesis and antimicrobial activities of novel quinazolin-4 (3H)-one derivatives containing a 1, 2, 4-triazolo [3, 4-b][1, 3, 4] thiadiazole moiety publication-title: J. Saudi Chem. Soc. – volume: 6 start-page: 208 year: 2010 end-page: 242 ident: bib0023 article-title: A recent portrait of bioactive triazoles publication-title: Curr. Bioact. Compd. – volume: 68 start-page: 237 year: 2011 end-page: 247 ident: bib0117 article-title: Synthesis of new functionalized 3-substituted [1, 2, 4] triazolo [4, 3-a] pyrimidine derivatives: potential antihypertensive agents publication-title: Acta Pol. Pharm – year: 2013 ident: bib0078 article-title: 1,2,4-triazole Derivatives As Sigma Receptor Inhibitors – volume: 21 start-page: 3509 year: 2012 end-page: 3513 ident: bib0112 article-title: Synthesis and antidepressant activity of di substituted-5-aryl-1, 2, 4-triazoles publication-title: Medicin. Chem. Res. – volume: 86 start-page: 705 year: 2019 end-page: 713 ident: bib0144 article-title: Synthesis of 5-methyl-2, 4-dihydro-3H-1, 2, 4-triazole-3-one's aryl Schiff base derivatives and investigation of carbonic anhydrase and cholinesterase (AChE, BuChE) inhibitory properties publication-title: Bioorg. Chem. – volume: 18 start-page: 10870 year: 2013 end-page: 10900 ident: bib0030 article-title: Italian chemists’ contributions to named reactions in organic synthesis: an historical perspective publication-title: Molecules – volume: 11 start-page: 16 year: 2020 ident: bib0009 article-title: Nitrogen-based heterocyclic compounds: a promising class of antiviral agents against chikungunya virus publication-title: Life – year: 2014 ident: bib0075 article-title: 7-([1,2,4]triazolo[1,5- – volume: 80 start-page: 9016 year: 2015 end-page: 9027 ident: bib0026 article-title: Synthesis of 1, 2, 4-triazoles via oxidative heterocyclization: selective C–N bond over C–S bond formation publication-title: J. Org. Chem. – year: 2020 ident: bib0066 article-title: Jak1 Pathway Inhibitors for the Treatment of Chronic Lung Allograft Dysfunction – volume: 1180 start-page: 344 year: 2019 end-page: 354 ident: bib0125 article-title: Design, synthesis and biological evaluation of Schiff bases of 4-amino-1, 2, 4-triazole derivatives as potent angiotensin converting enzyme inhibitors and antioxidant activities publication-title: J. Mol. Struct. – volume: 204 year: 2020 ident: bib0137 article-title: Synthesis, and biological evaluation of 3, 6-diaryl-[1, 2, 4] triazolo [4, 3-a] pyridine analogues as new potent tubulin polymerization inhibitors publication-title: Eur. J. Med. Chem. – volume: 21 start-page: 2109 year: 2021 end-page: 2133 ident: bib0017 article-title: Recent Progress in 1H-1, 2, 3-triazoles as potential antifungal agents publication-title: Curr. Top. Med. Chem. – volume: 30 start-page: 461 year: 1990 end-page: 467 ident: bib0053 article-title: Estazolam and flurazepam: a multicenter, placebo-controlled comparative study in outpatients with insomnia publication-title: J. Clinic. Pharmacol. – volume: 11 start-page: 661 year: 2008 end-page: 670 ident: bib0048 article-title: Pramiconazole, a triazole compound for the treatment of fungal infections publication-title: IDrugs – volume: 46 start-page: 225 year: 2021 end-page: 232 ident: bib0140 article-title: Design, synthesis, and biological evaluation of 1, 2, 4-thiadiazole-1, 2, 4-triazole derivatives bearing amide functionality as anticancer agents publication-title: Arab. J. Sci. Eng. – volume: 47 start-page: 517 year: 2015 end-page: 525 ident: bib0028 article-title: A simple and efficient synthesis of 3, 4, 5-trisubstituted/N-fused 1, 2, 4-triazoles via ceric ammonium nitrate catalyzed oxidative cyclization of amidrazones with aldehydes using polyethylene glycol as a recyclable reaction medium publication-title: Synthesis – volume: 11 start-page: 245 year: 1997 end-page: 250 ident: bib0060 article-title: Vorozole publication-title: Drugs Aging – volume: 1177 start-page: 131 year: 2019 end-page: 142 ident: bib0126 article-title: Synthesis, X-ray, spectroscopic characterization, DFT and antioxidant activity of 1, 2, 4-triazolo [1, 5-a] pyrimidine derivatives publication-title: J. Mol. Struct. – volume: 1224 year: 2021 ident: bib0129 article-title: An extensive research on aldose reductase inhibitory effects of new 4H-1, 2, 4-triazole derivatives publication-title: J. Mol. Struct. – volume: 14 start-page: 893 year: 2021 ident: bib0010 article-title: Pyrroles as privileged scaffolds in the search for new potential HIV inhibitors publication-title: Pharmaceuticals, – volume: 28 start-page: 11 year: 2018 end-page: 14 ident: bib0100 article-title: Isosteric ribavirin analogues: synthesis and antiviral activities publication-title: Bioorg. Med. Chem. Lett. – volume: 26 start-page: 404 issue: 03 year: 2015 ident: 10.1016/j.molstruc.2022.134487_bib0033 article-title: Microwave-assisted catalyst-free synthesis of substituted 1, 2, 4-triazoles publication-title: Synlett doi: 10.1055/s-0034-1379734 – volume: 94 year: 2020 ident: 10.1016/j.molstruc.2022.134487_bib0121 article-title: Preclinical evaluation of 1, 2, 4-triazole-based compounds targeting voltage-gated sodium channels (VGSCs) as promising anticonvulsant drug candidates publication-title: Bioorg. Chem. doi: 10.1016/j.bioorg.2019.103355 – volume: 1224 year: 2021 ident: 10.1016/j.molstruc.2022.134487_bib0129 article-title: An extensive research on aldose reductase inhibitory effects of new 4H-1, 2, 4-triazole derivatives publication-title: J. Mol. Struct. doi: 10.1016/j.molstruc.2020.129446 – volume: 114 year: 2021 ident: 10.1016/j.molstruc.2022.134487_bib0128 article-title: Design, synthesis and biological evaluation of glycolamide, glycinamide, and β-amino carbonyl 1, 2, 4-triazole derivatives as DPP-4 inhibitors publication-title: Bioorg. Chem. doi: 10.1016/j.bioorg.2021.105049 – volume: 68 start-page: 1319 issue: 9 year: 2008 ident: 10.1016/j.molstruc.2022.134487_bib0061 article-title: Anastrozole publication-title: Drugs doi: 10.2165/00003495-200868090-00007 – volume: 86 start-page: 690 year: 2014 ident: 10.1016/j.molstruc.2022.134487_bib0120 article-title: Studies on the anticonvulsant activity of 4-alkyl-1, 2, 4-triazole-3-thiones and their effect on GABAergic system publication-title: Eur. J. Med. Chem. doi: 10.1016/j.ejmech.2014.09.034 – volume: 31 start-page: 370 issue: 3 year: 2021 ident: 10.1016/j.molstruc.2022.134487_bib0085 article-title: New thieno [2, 3-b] pyridine-fused [1, 2, 4] triazolo [4, 3-a] pyrimidinone hybrids as potential MRSA and VRE inhibitors publication-title: Mendeleev Commun. doi: 10.1016/j.mencom.2021.04.029 – volume: 7 start-page: 668 issue: 1 year: 2011 ident: 10.1016/j.molstruc.2022.134487_bib0021 article-title: Advances in synthetic approach to and antifungal activity of triazoles publication-title: Beilstein J. Org. Chem. doi: 10.3762/bjoc.7.79 – volume: 19 start-page: 1298 issue: 16 year: 2019 ident: 10.1016/j.molstruc.2022.134487_bib0016 article-title: Exploring the chemistry and therapeutic potential of triazoles: a comprehensive literature review publication-title: Mini Rev. Med. Chem. doi: 10.2174/1389557519666190312162601 – year: 2021 ident: 10.1016/j.molstruc.2022.134487_bib0062 – volume: 62 start-page: 1539 issue: 10 year: 2002 ident: 10.1016/j.molstruc.2022.134487_bib0051 article-title: Rizatriptan publication-title: Drugs doi: 10.2165/00003495-200262100-00007 – volume: 27 start-page: 2171 issue: 10 year: 2017 ident: 10.1016/j.molstruc.2022.134487_bib0089 article-title: Design, synthesis, and in vitro evaluation of novel antifungal triazoles publication-title: Bioorg. Med. Chem. Lett. doi: 10.1016/j.bmcl.2017.03.062 – volume: 6 start-page: 208 issue: 4 year: 2010 ident: 10.1016/j.molstruc.2022.134487_bib0023 article-title: A recent portrait of bioactive triazoles publication-title: Curr. Bioact. Compd. doi: 10.2174/157340710793237281 – volume: 1237 year: 2021 ident: 10.1016/j.molstruc.2022.134487_bib0130 article-title: Novel pyrano-triazolo-pyrimidine derivatives as anti- α-amylase agents: synthesis, molecular docking investigations and computational analysis publication-title: J. Mol. Struct. doi: 10.1016/j.molstruc.2021.130346 – volume: 55 start-page: 2297 issue: 10 year: 2018 ident: 10.1016/j.molstruc.2022.134487_bib0006 article-title: Design, synthesis and SAR study of novel spiro [Pyrimido [5, 4-b] Quinoline-10, 5′-Pyrrolo [2, 3-d] Pyrimidine] derivatives as promising anticancer agents publication-title: J. Heterocycl. Chem. doi: 10.1002/jhet.3286 – volume: 11 start-page: 245 issue: 3 year: 1997 ident: 10.1016/j.molstruc.2022.134487_bib0060 article-title: Vorozole publication-title: Drugs Aging doi: 10.2165/00002512-199711030-00007 – volume: 16 start-page: 1395 issue: 11 year: 2015 ident: 10.1016/j.molstruc.2022.134487_bib0052 article-title: Residual effects of zolpidem, triazolam, rilmazafone and placebo in healthy elderly subjects: a randomized double-blind study publication-title: Sleep Med. doi: 10.1016/j.sleep.2015.05.021 – year: 2012 ident: 10.1016/j.molstruc.2022.134487_bib0082 – year: 2020 ident: 10.1016/j.molstruc.2022.134487_bib0067 – volume: 27 start-page: 132 issue: 2 year: 1984 ident: 10.1016/j.molstruc.2022.134487_bib0058 article-title: Alprazolam publication-title: Drugs doi: 10.2165/00003495-198427020-00002 – volume: 36 start-page: 630 issue: 5 year: 2003 ident: 10.1016/j.molstruc.2022.134487_bib0043 article-title: Voriconazole: a new triazole antifungal agent publication-title: Clinic. Infect. Dis. doi: 10.1086/367933 – volume: 81 start-page: 599 year: 2018 ident: 10.1016/j.molstruc.2022.134487_bib0096 article-title: Synthesis, antimicrobial activity and molecular modeling study of 3-(5-amino-(2H)-1, 2, 4-triazol-3-yl]-naphthyridinones as potential DNA-gyrase inhibitors publication-title: Bioorg. Chem. doi: 10.1016/j.bioorg.2018.08.031 – volume: 30 start-page: 461 issue: 5 year: 1990 ident: 10.1016/j.molstruc.2022.134487_bib0053 article-title: Estazolam and flurazepam: a multicenter, placebo-controlled comparative study in outpatients with insomnia publication-title: J. Clinic. Pharmacol. doi: 10.1002/j.1552-4604.1990.tb03486.x – volume: 10 start-page: 14170 issue: 24 year: 2020 ident: 10.1016/j.molstruc.2022.134487_bib0003 article-title: Benefits and applications of microwave-assisted synthesis of nitrogen containing heterocycles in medicinal chemistry publication-title: RSC Adv. doi: 10.1039/D0RA01378A – volume: 6 start-page: e05290 issue: 10 year: 2020 ident: 10.1016/j.molstruc.2022.134487_bib0127 article-title: Design and synthesis of coumarin-triazole hybrids: biocompatible anti-diabetic agents, in silico molecular docking and ADME screening publication-title: Heliyon doi: 10.1016/j.heliyon.2020.e05290 – volume: 21 start-page: 7742 issue: 24 year: 2013 ident: 10.1016/j.molstruc.2022.134487_bib0115 article-title: Design, synthesis, and biological evaluation of 1, 2, 4-triazole bearing 5-substituted biphenyl-2-sulfonamide derivatives as potential antihypertensive candidates publication-title: Bioorg. Med. Chem. doi: 10.1016/j.bmc.2013.10.017 – volume: 13 start-page: 1961 issue: 11 year: 2021 ident: 10.1016/j.molstruc.2022.134487_bib0019 article-title: The overview on the pharmacokinetic and pharmacodynamic interactions of triazoles publication-title: Pharmaceutics doi: 10.3390/pharmaceutics13111961 – year: 2019 ident: 10.1016/j.molstruc.2022.134487_bib0035 – year: 2020 ident: 10.1016/j.molstruc.2022.134487_bib0066 – volume: 25 start-page: 2664 issue: 13 year: 2015 ident: 10.1016/j.molstruc.2022.134487_bib0107 article-title: Synthesis and anti-inflammatory activity of new 1, 2, 4-triazole derivatives publication-title: Bioorg. Med. Chem. Lett. doi: 10.1016/j.bmcl.2015.04.079 – volume: 19 start-page: 1517 issue: 18 year: 2019 ident: 10.1016/j.molstruc.2022.134487_bib0008 article-title: A review on the antitumor activity of various nitrogenous-based heterocyclic compounds as NSCLC inhibitors publication-title: Mini Rev. Med. Chem. doi: 10.2174/1389557519666190312152358 – volume: 21 start-page: 2109 issue: 23 year: 2021 ident: 10.1016/j.molstruc.2022.134487_bib0017 article-title: Recent Progress in 1H-1, 2, 3-triazoles as potential antifungal agents publication-title: Curr. Top. Med. Chem. doi: 10.2174/1568026621666210913122828 – volume: 58 start-page: 612 issue: 6 year: 2004 ident: 10.1016/j.molstruc.2022.134487_bib0044 article-title: Posaconazole: a potent, extended-spectrum triazole anti-fungal for the treatment of serious fungal infections publication-title: Int. J. Clin. Pract. doi: 10.1111/j.1368-5031.2004.00167.x – volume: 61 start-page: 1558 issue: 10 year: 2015 ident: 10.1016/j.molstruc.2022.134487_bib0047 article-title: Isavuconazole: a new broad-spectrum triazole antifungal agent publication-title: Clinic. Infect. Dis. doi: 10.1093/cid/civ571 – volume: 46 start-page: 225 issue: 1 year: 2021 ident: 10.1016/j.molstruc.2022.134487_bib0140 article-title: Design, synthesis, and biological evaluation of 1, 2, 4-thiadiazole-1, 2, 4-triazole derivatives bearing amide functionality as anticancer agents publication-title: Arab. J. Sci. Eng. doi: 10.1007/s13369-020-04626-z – volume: 16 start-page: 119 issue: 1 year: 2020 ident: 10.1016/j.molstruc.2022.134487_bib0142 article-title: Synthesis and biological evaluation of 5-benzyl-3-pyridyl-1H-1, 2, 4-triazole derivatives as xanthine oxidase inhibitors publication-title: Med. Chem. doi: 10.2174/1573406415666190409112209 – year: 2013 ident: 10.1016/j.molstruc.2022.134487_bib0081 – volume: 54 start-page: 1537 issue: 2 year: 2017 ident: 10.1016/j.molstruc.2022.134487_bib0004 article-title: Design, synthesis, and characterization of some new bis-thiazoles publication-title: J. Heterocycl. Chem. doi: 10.1002/jhet.2741 – volume: 80 start-page: 9016 issue: 18 year: 2015 ident: 10.1016/j.molstruc.2022.134487_bib0026 article-title: Synthesis of 1, 2, 4-triazoles via oxidative heterocyclization: selective C–N bond over C–S bond formation publication-title: J. Org. Chem. doi: 10.1021/acs.joc.5b00956 – volume: 1180 start-page: 344 year: 2019 ident: 10.1016/j.molstruc.2022.134487_bib0125 article-title: Design, synthesis and biological evaluation of Schiff bases of 4-amino-1, 2, 4-triazole derivatives as potent angiotensin converting enzyme inhibitors and antioxidant activities publication-title: J. Mol. Struct. doi: 10.1016/j.molstruc.2018.12.008 – volume: 56 start-page: 1125 issue: 6 year: 1998 ident: 10.1016/j.molstruc.2022.134487_bib0059 article-title: Letrozole publication-title: Drugs doi: 10.2165/00003495-199856060-00020 – volume: 690 start-page: 99 issue: 1–3 year: 2012 ident: 10.1016/j.molstruc.2022.134487_bib0123 article-title: Effect of 4-(4-bromophenyl)-5-(3-chlorophenyl)-2, 4-dihydro-3H-1, 2, 4-triazole-3-thione on the anticonvulsant action of different classical antiepileptic drugs in the mouse maximal electroshock-induced seizure model publication-title: Eur. J. Pharmacol. doi: 10.1016/j.ejphar.2012.06.023 – volume: 25 start-page: 1909 issue: 8 year: 2020 ident: 10.1016/j.molstruc.2022.134487_bib0001 article-title: A review on recent advances in nitrogen-containing molecules and their biological applications publication-title: Molecules doi: 10.3390/molecules25081909 – volume: 46 start-page: 1 issue: 1 year: 1950 ident: 10.1016/j.molstruc.2022.134487_bib0018 article-title: The chemistry of the vicinal triazoles publication-title: Chem. Rev. doi: 10.1021/cr60143a001 – year: 2017 ident: 10.1016/j.molstruc.2022.134487_bib0071 – volume: 22 start-page: 1 issue: 1 year: 2014 ident: 10.1016/j.molstruc.2022.134487_bib0110 article-title: Synthesis, analgesic and anti-inflammatory activities of new methyl-imidazolyl-1, 3, 4-oxadiazoles and 1, 2, 4-triazoles publication-title: Daru J. Pharm. Sci. doi: 10.1186/2008-2231-22-22 – year: 2014 ident: 10.1016/j.molstruc.2022.134487_bib0074 – volume: 1177 start-page: 131 year: 2019 ident: 10.1016/j.molstruc.2022.134487_bib0126 article-title: Synthesis, X-ray, spectroscopic characterization, DFT and antioxidant activity of 1, 2, 4-triazolo [1, 5-a] pyrimidine derivatives publication-title: J. Mol. Struct. doi: 10.1016/j.molstruc.2018.09.046 – ident: 10.1016/j.molstruc.2022.134487_bib0114 doi: 10.23939/chcht14.02.214 – volume: 11 start-page: 16 issue: 1 year: 2020 ident: 10.1016/j.molstruc.2022.134487_bib0009 article-title: Nitrogen-based heterocyclic compounds: a promising class of antiviral agents against chikungunya virus publication-title: Life doi: 10.3390/life11010016 – volume: 5 start-page: 775 issue: 12 year: 2005 ident: 10.1016/j.molstruc.2022.134487_bib0046 article-title: Posaconazole: a broad-spectrum triazole antifungal publication-title: Lancet Infect. Dis. doi: 10.1016/S1473-3099(05)70297-8 – volume: 204 year: 2020 ident: 10.1016/j.molstruc.2022.134487_bib0137 article-title: Synthesis, and biological evaluation of 3, 6-diaryl-[1, 2, 4] triazolo [4, 3-a] pyridine analogues as new potent tubulin polymerization inhibitors publication-title: Eur. J. Med. Chem. doi: 10.1016/j.ejmech.2020.112625 – volume: 70 start-page: 1189 issue: 9 year: 2010 ident: 10.1016/j.molstruc.2022.134487_bib0050 article-title: Maraviroc publication-title: Drugs doi: 10.2165/11203940-000000000-00000 – volume: 46 start-page: 303 issue: 4 year: 1979 ident: 10.1016/j.molstruc.2022.134487_bib0056 article-title: The effect of etoperidone, a new potential antidepressant drug, on the central serotonin system publication-title: J. Neural Transm. doi: 10.1007/BF01259336 – volume: 18 start-page: 1334 issue: 6 year: 2016 ident: 10.1016/j.molstruc.2022.134487_bib0038 article-title: I2-catalyzed oxidative coupling reactions of hydrazones and amines and the application in the synthesis of 1, 3, 5-trisubstituted 1, 2, 4-triazoles publication-title: Org. Lett. doi: 10.1021/acs.orglett.6b00277 – volume: 15 start-page: 1 issue: 1 year: 2021 ident: 10.1016/j.molstruc.2022.134487_bib0095 article-title: Synthesis and biological evaluation of heterocyclic 1, 2, 4-triazole scaffolds as promising pharmacological agents publication-title: BMC Chem. doi: 10.1186/s13065-020-00717-y – year: 2014 ident: 10.1016/j.molstruc.2022.134487_bib0076 – volume: 11 start-page: 501 issue: 2 year: 2021 ident: 10.1016/j.molstruc.2022.134487_bib0124 article-title: Synthesis, antioxidant activity and molecular docking study of 1, 2, 4-triazole and their corresponding fused rings containing 2-methylphenol publication-title: Drug Deliv. – year: 2021 ident: 10.1016/j.molstruc.2022.134487_bib0065 – volume: 27 start-page: 3845 issue: 16 year: 2017 ident: 10.1016/j.molstruc.2022.134487_bib0098 article-title: Antileishmanial potential of fused 5-(pyrazin-2-yl)-4H-1, 2, 4-triazole-3-thiols: synthesis, biological evaluations and computational studies publication-title: Bioorg. Med. Chem. Lett. doi: 10.1016/j.bmcl.2017.06.053 – volume: 27 start-page: 4409 issue: 18 year: 2017 ident: 10.1016/j.molstruc.2022.134487_bib0105 article-title: Design, synthesis, anti-inflammatory activity, and molecular docking studies of perimidine derivatives containing triazole publication-title: Bioorg. Med. Chem. Lett. doi: 10.1016/j.bmcl.2017.08.014 – volume: 53 start-page: 608 issue: 4 year: 1997 ident: 10.1016/j.molstruc.2022.134487_bib0054 article-title: Nefazodone publication-title: Drugs doi: 10.2165/00003495-199753040-00006 – volume: 28 start-page: 11 issue: 1 year: 2018 ident: 10.1016/j.molstruc.2022.134487_bib0100 article-title: Isosteric ribavirin analogues: synthesis and antiviral activities publication-title: Bioorg. Med. Chem. Lett. doi: 10.1016/j.bmcl.2017.11.029 – year: 2019 ident: 10.1016/j.molstruc.2022.134487_bib0070 – volume: 20 start-page: 2150 issue: 18 year: 2020 ident: 10.1016/j.molstruc.2022.134487_bib0002 article-title: Nitrogen-containing heterocycles as anticancer agents: an overview publication-title: Anti-Cancer Agents Medicin. Chem. doi: 10.2174/1871520620666200705214917 – volume: 18 start-page: 2535 issue: 10 year: 2021 ident: 10.1016/j.molstruc.2022.134487_bib0015 article-title: A review on ‘triazoles’: their chemistry, synthesis and pharmacological potentials publication-title: J. Iran. Chem. Soc. doi: 10.1007/s13738-021-02231-x – ident: 10.1016/j.molstruc.2022.134487_bib0083 – volume: 76 start-page: 1177 issue: 4 year: 2011 ident: 10.1016/j.molstruc.2022.134487_bib0034 article-title: Rapid synthesis of 1, 3, 5-substituted 1, 2, 4-triazoles from carboxylic acids, amidines, and hydrazines publication-title: J. Org. Chem. doi: 10.1021/jo1023393 – volume: 11 start-page: 661 issue: 9 year: 2008 ident: 10.1016/j.molstruc.2022.134487_bib0048 article-title: Pramiconazole, a triazole compound for the treatment of fungal infections publication-title: IDrugs – volume: 131 start-page: 15080 issue: 42 year: 2009 ident: 10.1016/j.molstruc.2022.134487_bib0036 article-title: Facile synthesis of 1, 2, 4-triazoles via a copper-catalyzed tandem addition− oxidative cyclization publication-title: J. Am. Chem. Soc. doi: 10.1021/ja905056z – volume: 92 year: 2019 ident: 10.1016/j.molstruc.2022.134487_bib0136 article-title: Novel [1, 2, 4] triazolo [1, 5-a] pyrimidine derivatives as potent antitubulin agents: design, multicomponent synthesis and antiproliferative activities publication-title: Bioorg. Chem. doi: 10.1016/j.bioorg.2019.103260 – volume: 1175 start-page: 280 year: 2019 ident: 10.1016/j.molstruc.2022.134487_bib0143 article-title: Synthesis, biological activities and molecular docking studies of some novel 2, 4, 5-trisubstituted-1, 2, 4-triazole-3-one derivatives as potent tyrosinase inhibitors publication-title: J. Mol. Struct. doi: 10.1016/j.molstruc.2018.07.065 – volume: 142 start-page: 345 year: 2020 ident: 10.1016/j.molstruc.2022.134487_bib0141 article-title: Exploring biological efficacy of coumarin clubbed thiazolo [3, 2–b][1, 2, 4] triazoles as efficient inhibitors of urease: a biochemical and in silico approach publication-title: Int. J. Biol. Macromol. doi: 10.1016/j.ijbiomac.2019.09.105 – volume: 18 start-page: 3950 issue: 21 year: 2020 ident: 10.1016/j.molstruc.2022.134487_bib0011 article-title: Recent advances in the synthesis of imidazoles publication-title: Org. Biomol. Chem. doi: 10.1039/D0OB00350F – volume: 27 start-page: 835 issue: 3 year: 2022 ident: 10.1016/j.molstruc.2022.134487_bib0132 article-title: Design, synthesis of new 1, 2, 4-triazole/1, 3, 4-thiadiazole with spiroindoline, imidazo [4, 5-b] quinoxaline and thieno [2, 3-d] pyrimidine from isatin derivatives as anticancer agents publication-title: Molecules doi: 10.3390/molecules27030835 – ident: 10.1016/j.molstruc.2022.134487_bib0077 – volume: 56 start-page: 1437 issue: 4 year: 2019 ident: 10.1016/j.molstruc.2022.134487_bib0005 article-title: Design, synthesis, and anticancer activity of novel benzothiazole analogues publication-title: J. Heterocycl. Chem. doi: 10.1002/jhet.3524 – volume: 28 start-page: 1641 issue: 14 year: 1981 ident: 10.1016/j.molstruc.2022.134487_bib0057 article-title: A new approach to the treatment of atherosclerosis and trapidil as an antagonist to platelet-derived growth factor publication-title: Life Sci. doi: 10.1016/0024-3205(81)90320-9 – year: 2013 ident: 10.1016/j.molstruc.2022.134487_bib0080 – volume: 14 start-page: 893 issue: 9 year: 2021 ident: 10.1016/j.molstruc.2022.134487_bib0010 article-title: Pyrroles as privileged scaffolds in the search for new potential HIV inhibitors publication-title: Pharmaceuticals, doi: 10.3390/ph14090893 – volume: 54 start-page: 931 year: 2012 ident: 10.1016/j.molstruc.2022.134487_bib0113 article-title: Synthesis, antidepressant and antimicrobial activities of some novel stearic acid analogues publication-title: Eur. J. Med. Chem. doi: 10.1016/j.ejmech.2012.06.025 – year: 2021 ident: 10.1016/j.molstruc.2022.134487_bib0063 – volume: 351 issue: 3–4 year: 2018 ident: 10.1016/j.molstruc.2022.134487_bib0104 article-title: Synthesis, p38α MAP kinase inhibition, anti-inflammatory activity, and molecular docking studies of 1, 2, 4-triazole-based benzothiazole-2-amines publication-title: Arch. Pharm. – volume: 45 start-page: 1083 issue: 08 year: 2013 ident: 10.1016/j.molstruc.2022.134487_bib0037 article-title: A Safe Synthesis of 1, 5-Disubstituted 3-Amino-1H-1, 2, 4-triazoles from 1, 3, 4-Oxadiazolium Hexafluorophosphates publication-title: Synthesis doi: 10.1055/s-0032-1316877 – volume: 29 start-page: 1682 issue: 13 year: 2019 ident: 10.1016/j.molstruc.2022.134487_bib0097 article-title: Ultrasonication-ionic liquid synergy for the synthesis of new potent anti-tuberculosis 1, 2, 4-triazol-1-yl-pyrazole based spirooxindolopyrrolizidines publication-title: Bioorg. Med. Chem. Lett. doi: 10.1016/j.bmcl.2019.04.026 – volume: 143 start-page: 1840 year: 2018 ident: 10.1016/j.molstruc.2022.134487_bib0087 article-title: Molecular docking, design, synthesis and antifungal activity study of novel triazole derivatives publication-title: Eur. J. Med. Chem. doi: 10.1016/j.ejmech.2017.10.081 – year: 2017 ident: 10.1016/j.molstruc.2022.134487_bib0072 – volume: 17 start-page: 2894 issue: 12 year: 2015 ident: 10.1016/j.molstruc.2022.134487_bib0029 article-title: Copper-catalyzed oxidative C (sp3)–H functionalization for facile synthesis of 1, 2, 4-triazoles and 1, 3, 5-triazines from amidines publication-title: Org. Lett. doi: 10.1021/acs.orglett.5b00995 – volume: 4 start-page: 331 issue: 4 year: 1994 ident: 10.1016/j.molstruc.2022.134487_bib0055 article-title: Trazodone publication-title: Drugs Aging doi: 10.2165/00002512-199404040-00006 – volume: 12 start-page: 2114 issue: 13 year: 2014 ident: 10.1016/j.molstruc.2022.134487_bib0109 article-title: Discovery of potential anti-inflammatory drugs: diaryl-1, 2, 4-triazoles bearing N-hydroxyurea moiety as dual inhibitors of cyclooxygenase-2 and 5-lipoxygenase publication-title: Org. Biomol. Chem. doi: 10.1039/c3ob41936c – volume: 67 start-page: 325 year: 2013 ident: 10.1016/j.molstruc.2022.134487_bib0145 article-title: A structure–activity relationship study of 1, 2, 4-triazolo [1, 5-a][1, 3, 5] triazin-5, 7-dione and its 5-thioxo analogues on anti-thymidine phosphorylase and associated anti-angiogenic activities publication-title: Eur. J. Medicin. Chem. doi: 10.1016/j.ejmech.2013.06.051 – volume: 112 year: 2021 ident: 10.1016/j.molstruc.2022.134487_bib0084 article-title: Design, synthesis, and antibacterial evaluation of new quinoline-1, 3, 4-oxadiazole and quinoline-1, 2, 4-triazole hybrids as potential inhibitors of DNA gyrase and topoisomerase IV publication-title: Bioorg. Chem. doi: 10.1016/j.bioorg.2021.104920 – volume: 21 start-page: 1023 issue: 3 year: 2011 ident: 10.1016/j.molstruc.2022.134487_bib0116 article-title: Triazole incorporated pyridazinones as a new class of antihypertensive agents: design, synthesis and in vivo screening publication-title: Bioorg. Med. Chem. Lett. doi: 10.1016/j.bmcl.2010.12.028 – volume: 18 start-page: 10870 issue: 9 year: 2013 ident: 10.1016/j.molstruc.2022.134487_bib0030 article-title: Italian chemists’ contributions to named reactions in organic synthesis: an historical perspective publication-title: Molecules doi: 10.3390/molecules180910870 – volume: 145 start-page: 1 year: 2018 ident: 10.1016/j.molstruc.2022.134487_bib0092 article-title: Synthesis and antimicrobial activity of pyrimidinyl 1, 3, 4-oxadiazoles, 1, 3, 4-thiadiazoles and 1, 2, 4-triazoles publication-title: Eur. J. Med. Chem. doi: 10.1016/j.ejmech.2017.12.067 – volume: 17 start-page: 1184 issue: 5 year: 2015 ident: 10.1016/j.molstruc.2022.134487_bib0032 article-title: One-pot synthesis of 3, 4, 5-trisubstituted 1, 2, 4-triazoles via the addition of hydrazides to activated secondary amides publication-title: Org. Lett. doi: 10.1021/acs.orglett.5b00128 – volume: 39 start-page: 457 issue: 2 year: 2021 ident: 10.1016/j.molstruc.2022.134487_bib0103 article-title: Synthesis, characterization and anti-inflammatory activity evaluation of 1, 2, 4-triazole and its derivatives as a potential scaffold for the synthesis of drugs against prostaglandin-endoperoxide synthase publication-title: J. Biomol. Struct. Dyn. doi: 10.1080/07391102.2019.1711193 – volume: 68 start-page: 237 issue: 2 year: 2011 ident: 10.1016/j.molstruc.2022.134487_bib0117 article-title: Synthesis of new functionalized 3-substituted [1, 2, 4] triazolo [4, 3-a] pyrimidine derivatives: potential antihypertensive agents publication-title: Acta Pol. Pharm – volume: 544 start-page: 4 issue: 1 year: 1988 ident: 10.1016/j.molstruc.2022.134487_bib0040 article-title: Design and evaluation of a systemically active agent, fluconazole publication-title: Ann. N. Y. Acad. Sci. doi: 10.1111/j.1749-6632.1988.tb40385.x – volume: 32 start-page: 3388 issue: 8 year: 2020 ident: 10.1016/j.molstruc.2022.134487_bib0131 article-title: Synthesis of novel indole, 1,2,4-triazole derivatives as potential glucosidase inhibitors publication-title: J. King Saud Univ. doi: 10.1016/j.jksus.2020.09.026 – volume: 21 start-page: 3509 issue: 11 year: 2012 ident: 10.1016/j.molstruc.2022.134487_bib0112 article-title: Synthesis and antidepressant activity of di substituted-5-aryl-1, 2, 4-triazoles publication-title: Medicin. Chem. Res. doi: 10.1007/s00044-011-9902-z – volume: 47 start-page: 517 issue: 04 year: 2015 ident: 10.1016/j.molstruc.2022.134487_bib0028 article-title: A simple and efficient synthesis of 3, 4, 5-trisubstituted/N-fused 1, 2, 4-triazoles via ceric ammonium nitrate catalyzed oxidative cyclization of amidrazones with aldehydes using polyethylene glycol as a recyclable reaction medium publication-title: Synthesis – volume: 70 start-page: 1116 issue: 6 year: 2018 ident: 10.1016/j.molstruc.2022.134487_bib0122 article-title: Synthesis and anticonvulsant screening of 1, 2, 4-triazole derivatives publication-title: Pharmacol. Rep. doi: 10.1016/j.pharep.2018.06.007 – volume: 24 start-page: 303 issue: 4 year: 2013 ident: 10.1016/j.molstruc.2022.134487_bib0090 article-title: Design and synthesis of novel antifungal triazole derivatives with good activity and water solubility publication-title: Chin. Chem. Lett. doi: 10.1016/j.cclet.2013.01.047 – volume: 8 start-page: 123 issue: 2 year: 2016 ident: 10.1016/j.molstruc.2022.134487_bib0049 article-title: Ribavirin: past, present and future publication-title: World J. Hepatol. doi: 10.4254/wjh.v8.i2.123 – year: 2019 ident: 10.1016/j.molstruc.2022.134487_bib0069 – year: 2014 ident: 10.1016/j.molstruc.2022.134487_bib0075 – start-page: 82 issue: 1 year: 2010 ident: 10.1016/j.molstruc.2022.134487_bib0022 article-title: Current biological and synthetic profile of triazoles: a review publication-title: Annals Biol. Res – volume: 36 start-page: 2239 issue: 10 year: 1992 ident: 10.1016/j.molstruc.2022.134487_bib0041 article-title: Modulation of interactions of Candida albicans and endothelial cells by fluconazole and amphotericin B publication-title: Antimicrob. Agents Chemother. doi: 10.1128/AAC.36.10.2239 – volume: 73 start-page: 217 year: 2014 ident: 10.1016/j.molstruc.2022.134487_bib0111 article-title: Design, synthesis and evaluation of the antidepressant and anticonvulsant activities of triazole-containing quinolinones publication-title: Eur. J. Med. Chem. doi: 10.1016/j.ejmech.2013.12.014 – volume: 61 start-page: 87 issue: 2 year: 1961 ident: 10.1016/j.molstruc.2022.134487_bib0025 article-title: The chemistry of 1, 2, 4-triazoles publication-title: Chem. Rev. doi: 10.1021/cr60210a001 – volume: 26 start-page: 4213 issue: 14 year: 2021 ident: 10.1016/j.molstruc.2022.134487_bib0012 article-title: Imidazoles as potential anticancer agents: an update on recent studies publication-title: Molecules doi: 10.3390/molecules26144213 – volume: 22 start-page: 101 issue: 1 year: 2018 ident: 10.1016/j.molstruc.2022.134487_bib0093 article-title: Synthesis and antimicrobial activities of novel quinazolin-4 (3H)-one derivatives containing a 1, 2, 4-triazolo [3, 4-b][1, 3, 4] thiadiazole moiety publication-title: J. Saudi Chem. Soc. doi: 10.1016/j.jscs.2017.07.008 – volume: 11 start-page: 5482 issue: 23 year: 2009 ident: 10.1016/j.molstruc.2022.134487_bib0039 article-title: Highly efficient cyanoimidation of aldehydes publication-title: Org. Lett. doi: 10.1021/ol902207h – volume: 29 start-page: 1862 issue: 9 year: 2007 ident: 10.1016/j.molstruc.2022.134487_bib0045 article-title: Posaconazole: an extended-spectrum triazole antifungal agent publication-title: Clin. Ther. doi: 10.1016/j.clinthera.2007.09.015 – start-page: S1 year: 1987 ident: 10.1016/j.molstruc.2022.134487_bib0042 article-title: First international symposium on itraconazole: a summary publication-title: Rev. Infect. Dis. doi: 10.1093/clinids/9.Supplement_1.S1 – volume: 80 start-page: 1789 issue: 3 year: 2015 ident: 10.1016/j.molstruc.2022.134487_bib0027 article-title: Copper-catalyzed one-pot synthesis of 1, 2, 4-triazoles from nitriles and hydroxylamine publication-title: J. Org. Chem. doi: 10.1021/jo502709t – volume: 55 start-page: 556 issue: 6 year: 2021 ident: 10.1016/j.molstruc.2022.134487_bib0133 article-title: Synthesis, antiproliferative and antioxidant activity of 3-mercapto-1, 2, 4-triazole derivatives as combretastatin A-4 analogues publication-title: Pharm. Chem. J. doi: 10.1007/s11094-021-02459-0 – volume: 96 year: 2020 ident: 10.1016/j.molstruc.2022.134487_bib0135 article-title: Structure-based design and optimization of pyrimidine-and 1, 2, 4-triazolo [4, 3-a] pyrimidine-based matrix metalloproteinase-10/13 inhibitors via Dimroth rearrangement towards targeted polypharmacology publication-title: Bioorg. Chem. – year: 2013 ident: 10.1016/j.molstruc.2022.134487_bib0079 – volume: 26 start-page: 1162 issue: 4 year: 2021 ident: 10.1016/j.molstruc.2022.134487_bib0139 article-title: Synthesis, characterization and in vitro evaluation of novel 5-ene-thiazolo [3, 2-b][1, 2, 4] triazole-6 (5 h)-ones as possible anticancer agents publication-title: Molecules doi: 10.3390/molecules26041162 – volume: 57 start-page: 390 issue: 1 year: 2020 ident: 10.1016/j.molstruc.2022.134487_bib0007 article-title: Design, synthesis, anticancer, antibacterial, and antifungal evaluation of 4-aminoquinoline-1, 3, 5-triazine derivatives publication-title: J. Heterocycl. Chem. doi: 10.1002/jhet.3791 – volume: 11 start-page: 456 issue: 5 year: 2013 ident: 10.1016/j.molstruc.2022.134487_bib0020 article-title: Triazoles: a valuable insight into recent developments and biological activities publication-title: Chin. J. Nat. Med. – volume: 29 start-page: 383 issue: 3 year: 2019 ident: 10.1016/j.molstruc.2022.134487_bib0146 article-title: Synthesis, biological evaluation and 3D-QSAR studies of 1, 2, 4-triazole-5-substituted carboxylic acid bioisosteres as uric acid transporter 1 (URAT1) inhibitors for the treatment of hyperuricemia associated with gout publication-title: Bioorg. Med. Chem. Lett. doi: 10.1016/j.bmcl.2018.12.036 – volume: 26 start-page: 1 issue: 14 year: 2021 ident: 10.1016/j.molstruc.2022.134487_bib0086 article-title: Chromenol derivatives as novel antifungal agents: synthesis, in silico and in vitro evaluation publication-title: Molecules doi: 10.3390/molecules26144304 – volume: 68 start-page: 2045 issue: 8 year: 2012 ident: 10.1016/j.molstruc.2022.134487_bib0031 article-title: Synthesis of 1, 3, 5-trisubstituted-1, 2, 4-triazoles by microwave-assisted N-acylation of amide derivatives and the consecutive reaction with hydrazine hydrochlorides publication-title: Tetrahedron doi: 10.1016/j.tet.2012.01.003 – year: 2020 ident: 10.1016/j.molstruc.2022.134487_bib0068 – volume: 144 start-page: 255 year: 2018 ident: 10.1016/j.molstruc.2022.134487_bib0088 article-title: The synthesis, antifungal and apoptotic effects of triazole-oxadiazoles against Candida species publication-title: Eur. J. Med. Chem. doi: 10.1016/j.ejmech.2017.12.020 – volume: 60 start-page: 208 year: 2013 ident: 10.1016/j.molstruc.2022.134487_bib0119 article-title: Synthesis, characterization and preliminary anticonvulsant evaluation of some 4-alkyl-1, 2, 4-triazoles publication-title: Eur. J. Med. Chem. doi: 10.1016/j.ejmech.2012.11.026 – volume: 218 year: 2021 ident: 10.1016/j.molstruc.2022.134487_bib0138 article-title: Identification of novel 1, 3-diaryl-1, 2, 4-triazole-capped histone deacetylase 6 inhibitors with potential anti-gastric cancer activity publication-title: Eur. J. Med. Chem. doi: 10.1016/j.ejmech.2021.113392 – year: 2013 ident: 10.1016/j.molstruc.2022.134487_bib0078 – volume: 23 start-page: 2518 issue: 10 year: 2015 ident: 10.1016/j.molstruc.2022.134487_bib0108 article-title: Novel thiazolo [3, 2-b]-1, 2, 4-triazoles derived from naproxen with analgesic/anti-inflammatory properties: synthesis, biological evaluation and molecular modeling studies publication-title: Bioorg. Med. Chem. doi: 10.1016/j.bmc.2015.03.049 – year: 2016 ident: 10.1016/j.molstruc.2022.134487_bib0073 – volume: 14 start-page: 224 issue: 3 year: 2021 ident: 10.1016/j.molstruc.2022.134487_bib0014 article-title: 1, 2, 4-Triazoles as important antibacterial agents publication-title: Pharmaceuticals doi: 10.3390/ph14030224 – volume: 57 start-page: 407 year: 2012 ident: 10.1016/j.molstruc.2022.134487_bib0094 article-title: Synthesis, spectral characterization and biological evaluation of a novel series of 6-arylsubstituted-3-[2-(4-substitutedphenyl) propan-2-yl]-7H-[1, 2, 4] triazolo [3, 4-b][1, 3, 4] thiadiazines publication-title: Eur. J. Med. Chem. doi: 10.1016/j.ejmech.2012.06.059 – volume: 107 year: 2021 ident: 10.1016/j.molstruc.2022.134487_bib0101 article-title: Probing phenylcarbamoylazinane-1, 2, 4-triazole amides derivatives as lipoxygenase inhibitors along with cytotoxic, ADME and molecular docking studies publication-title: Bioorg. Chem. doi: 10.1016/j.bioorg.2020.104525 – volume: 25 start-page: 4064 issue: 15 year: 2017 ident: 10.1016/j.molstruc.2022.134487_bib0099 article-title: 1, 2, 4-Triazole and 1, 3, 4-oxadiazole analogues: synthesis, MO studies, in silico molecular docking studies, antimalarial as DHFR inhibitor and antimicrobial activities publication-title: Bioorg. Med. Chem. doi: 10.1016/j.bmc.2017.05.054 – volume: 10 start-page: 33 issue: 1 year: 2021 ident: 10.1016/j.molstruc.2022.134487_bib0118 article-title: Synthesis and characterization of 4-amino-4H-1, 2, 4-triazole derivatives: anticonvulsant activity publication-title: Curr. Chem. Lett. doi: 10.5267/j.ccl.2020.7.002 – volume: 86 start-page: 705 year: 2019 ident: 10.1016/j.molstruc.2022.134487_bib0144 article-title: Synthesis of 5-methyl-2, 4-dihydro-3H-1, 2, 4-triazole-3-one's aryl Schiff base derivatives and investigation of carbonic anhydrase and cholinesterase (AChE, BuChE) inhibitory properties publication-title: Bioorg. Chem. doi: 10.1016/j.bioorg.2019.02.045 – year: 2021 ident: 10.1016/j.molstruc.2022.134487_bib0064 – volume: 67 start-page: 459 issue: 4 year: 2020 ident: 10.1016/j.molstruc.2022.134487_bib0024 article-title: Exploring recent developments on 1, 2, 4-triazole: synthesis and biological applications publication-title: J. Chin. Chem. Soc. doi: 10.1002/jccs.201900304 – volume: 95 year: 2020 ident: 10.1016/j.molstruc.2022.134487_bib0134 article-title: Design and synthesis of newer 1, 3, 4-oxadiazole and 1, 2, 4-triazole based Topsentin analogues as anti-proliferative agent targeting tubulin publication-title: Bioorg. Chem. doi: 10.1016/j.bioorg.2019.103519 – volume: 75 start-page: 242 year: 2017 ident: 10.1016/j.molstruc.2022.134487_bib0106 article-title: Novel quinoline incorporating 1, 2, 4-triazole/oxime hybrids: synthesis, molecular docking, anti-inflammatory, COX inhibition, ulceroginicity and histopathological investigations publication-title: Bioorg. Chem. doi: 10.1016/j.bioorg.2017.09.018 – volume: 46 start-page: 4117 issue: 9 year: 2011 ident: 10.1016/j.molstruc.2022.134487_bib0091 article-title: New azole antifungal agents with novel modes of action: synthesis and biological studies of new tridentate ligands based on pyrazole and triazole publication-title: Eur. J. Med. Chem. doi: 10.1016/j.ejmech.2011.06.012 – volume: 115 year: 2021 ident: 10.1016/j.molstruc.2022.134487_bib0102 article-title: Exploring phenylcarbamoylazinane-1, 2, 4-triazole thioethers as lipoxygenase inhibitors supported with in vitro, in silico and cytotoxic studies publication-title: Bioorg. Chem. doi: 10.1016/j.bioorg.2021.105261 – volume: 180 start-page: 656 year: 2019 ident: 10.1016/j.molstruc.2022.134487_bib0013 article-title: Triazole derivatives as inhibitors of Alzheimer's disease: current developments and structure-activity relationships publication-title: Eur. J. Med. Chem. doi: 10.1016/j.ejmech.2019.07.059 |
| SSID | ssj0001101 |
| Score | 2.564336 |
| SecondaryResourceType | review_article |
| Snippet | •1,2,4-Triazole based aromatic and heterocyclic compounds holds tremendous potential in the medicinal chemistry.•Different biological targets for... |
| SourceID | crossref elsevier |
| SourceType | Enrichment Source Index Database Publisher |
| StartPage | 134487 |
| SubjectTerms | 1,2,4-Triazole Biological activity Drug design Heterocyclic chemistry Structure-activity relationship Synthesis |
| Title | An updated review on diverse range of biological activities of 1,2,4-triazole derivatives: Insight into structure activity relationship |
| URI | https://dx.doi.org/10.1016/j.molstruc.2022.134487 |
| Volume | 1274 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1LS8NAEF6KInoRrYr1UfbgsWm7r6bxVoqlKvak4C1kX1ipSekL9ODVv-1OktUKggev2UwIO5OdmfB93yB0wSzIiBkWKKFowHVXBi4LmsClIteAGCOFBnLy3agzfOA3j-KxgvqeCwOwyvLsL870_LQur7TK3WxNx2Pg-MLfiw5QRSmMSwcGOw8hypvv3zAPl96IVwyHu9dYws_Nl2ySy7S6PpHSJmGuVwl_T1BrSWewh3bLahH3ihfaRxWTVtF23w9pq6KtHMGp5gfoo5fi5RT6d40LPgrOUqxz2IXBM-AQ4MziQnQJPIOB0rDKBVVhgTRogwcwxOMtmxisXWSuclHw-SW-TufQw-NxushwoTi7nBn_gFc884i6p_H0ED0Mru77w6CcshAoRugi6Ebtjiu7ktAanWir3QfajThxhQ2zRhHrjgApEqpFRIWKmJREGlflcVdnKSVDy47QRpql5hhha7mWLFRCmIRbwSXtGioZtQm1JGybGhJ-a2NVSpDDJIxJ7LFmz7F3SQwuiQuX1FDry25aiHD8aRF5z8U_wil2meIP25N_2J6iHZhHD7BuIs7Qhls3565qWch6HpZ1tNm7vh2OPgEZ9PAv |
| linkProvider | Elsevier |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9NAEB6VIlQuqBQQBQp7gFs36b7iGIlDVagS-ji1Um_G-xKpgh0laVE5cOUH8QeZsb1QJKQeUK9ez8qamZ3HeuYbgNcqEoxYUNwZJ7n2Q8vRCwaOrggTkBCs8dScfHQ8GJ3qj2fmbAV-pl4YKqvsbH9r0xtr3T3pd9zszyYT6vGl24sBtYpKGpfeVVYehKuvmLct3o3fo5DfSLn_4WRvxLvRAtwpIZd8mO8MMNYosxh86aNHrRzmWqA3VzE4EVHvrSmlN7k0LlfWChswtNEYXDhns6hw3ztwV6O5oLEJve9_6krQn4oEUU6fd60t-bz3pZ42uLCYmErZEwqTo-zfHvGal9tfhwddeMp2Ww48hJVQbcDaXpoKtwH3mpJRt3gEP3YrdjGjCwPP2gYYVlfMN3Uegc2paYHVkbUoT6QKjHooLhsEV1oQ23Jbc5oa8q2eBubxKFw2KOSLt2xcLejSgE2qZc1aiNuLeUgbXLF5KuH7PJk9htNb4f0TWK3qKjwFFqP2VmXOmFDqaLSVwyCtkrGUUWQ7YRNMYm3hOsxzGr0xLVJx23mRRFKQSIpWJJvQ_003a1E_bqTIk-SKv_S3QNd0A-2z_6B9BWujk6PD4nB8fPAc7uMK_ZbnwryAVXw3bGHItLQvGxVl8Om2z8Qvp_orqA |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=An+updated+review+on+diverse+range+of+biological+activities+of+1%2C2%2C4-triazole+derivatives%3A+Insight+into+structure+activity+relationship&rft.jtitle=Journal+of+molecular+structure&rft.au=Gupta%2C+Ojasvi&rft.au=Pradhan%2C+Tathagata&rft.au=Chawla%2C+Gita&rft.date=2023-02-15&rft.pub=Elsevier+B.V&rft.issn=0022-2860&rft.eissn=1872-8014&rft.volume=1274&rft_id=info:doi/10.1016%2Fj.molstruc.2022.134487&rft.externalDocID=S0022286022021329 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0022-2860&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0022-2860&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0022-2860&client=summon |